usell.com (PXHI) S-1/A 5 Jun 14 IPO registration (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2014
Document Information [Line Items]	'
Entity Registrant Name	'usell.com, Inc.
Entity Central Index Key	'0001271075
Entity Filer Category	'Smaller Reporting Company
Document Type	'S-1
Amendment Flag	'false
Document Period End Date	31-Mar-14

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current Assets:	'	'	'
Cash and cash equivalents	$1,581,514	$489,166	$1,604,587
Accounts receivable, net	117,388	184,718	154,481
Other receivables	0	29,257	269
Prepaid expenses and other current assets	137,460	95,808	88,705
Total Current Assets	1,836,362	798,949	1,848,042
Property and equipment, net	6,244	7,289	6,506
Other Assets:	'	'	'
Intangible assets, net	828,473	806,964	624,153
Other assets	25,875	34,520	34,875
Total Other Assets	'	841,484	659,028
Total Assets	2,696,954	1,647,722	2,513,576
Current Liabilities:	'	'	'
Accounts payable	637,069	651,296	634,083
Accrued expenses	337,437	327,913	553,749
Deferred revenue	92,354	87,313	2,309
Derivative liability	0	1,001,385	153,776
Total Current Liabilities	1,066,860	2,067,907	1,343,917
Convertible notes payable, net of discount	0	246,128	0
Total Liabilities	1,066,860	2,314,035	1,343,917
Stockholders' Equity (Deficit):	'	'	'
Common stock; $0.0001 par value; 650,000,000 shares authorized; 5,878,535 and 4,973,073 shares issued, respectively, and 5,822,983 and 4,907,462 shares outstanding, respectively	582	490	314
Additional paid in capital	49,229,887	44,087,232	41,660,361
Accumulated deficit	-47,600,505	-44,754,133	-40,491,277
Total Stockholders' Equity (Deficit)	1,630,094	-666,313	1,169,659
Total Liabilities and Stockholders' Equity (Deficit)	2,696,954	1,647,722	2,513,576
Series A Convertible Preferred Stock [Member]	'	'	'
Stockholders' Equity (Deficit):	'	'	'
Convertible Preferred Stock, Value	10	0	18
Series B Convertible Preferred Stock [Member]	'	'	'
Stockholders' Equity (Deficit):	'	'	'
Convertible Preferred Stock, Value	95	98	208
Series C Convertible Preferred Stock [Member]	'	'	'
Stockholders' Equity (Deficit):	'	'	'
Convertible Preferred Stock, Value	15	0	'
Series D Convertible Preferred Stock [Member]	'	'	'
Stockholders' Equity (Deficit):	'	'	'
Convertible Preferred Stock, Value	0	0	35
Series E Convertible Preferred Stock [Member]	'	'	'
Stockholders' Equity (Deficit):	'	'	'
Convertible Preferred Stock, Value	$10	$0	'

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets [Parenthetical] (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Common stock, par value (in dollars per share)	$0.00	$0.00	$0.00
Common stock, shares authorized	650,000,000	650,000,000	650,000,000
Common stock, shares issued	5,878,535	4,973,073	3,509,749
Common stock, shares outstanding	5,822,983	4,907,462	3,143,082
Series A Convertible Preferred Stock [Member]	'	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00	$0.00
Preferred stock, shares authorized	325,000	325,000	10,000,000
Preferred stock, shares issued	100,000	0	177,906
Preferred stock, shares outstanding	100,000	0	177,906
Preferred stock, liquidation value (in dollars)	$300,000	$0	'
Series B Convertible Preferred Stock [Member]	'	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00	$0.00
Preferred stock, shares authorized	4,000,000	4,000,000	4,000,000
Preferred stock, shares issued	951,250	976,250	2,076,250
Preferred stock, shares outstanding	951,250	976,250	2,076,250
Preferred stock, liquidation value (in dollars)	951,250	976,250	2,076,250
Series C Convertible Preferred Stock [Member]	'	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00	'
Preferred stock, shares authorized	146,667	146,667	'
Preferred stock, shares issued	146,667	0	'
Preferred stock, shares outstanding	146,667	0	'
Series D Convertible Preferred Stock [Member]	'	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00	$0.00
Preferred stock, shares authorized	350,000	350,000	350,000
Preferred stock, shares issued	0	0	350,000
Preferred stock, shares outstanding	0	0	350,000
Preferred stock, liquidation value (in dollars)	'	$0	$3,500,000
Series E Convertible Preferred Stock [Member]	'	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00	'
Preferred stock, shares authorized	103,232	103,232	'
Preferred stock, shares issued	103,232	0	'
Preferred stock, shares outstanding	103,232	0	'

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Revenue	$1,005,999	$1,046,398	$5,371,381	$2,383,466
Costs and Expenses	'	'	'	'
Cost of revenue	126,544	81,606	416,233	222,036
Sales and marketing expenses	1,085,439	871,640	4,729,552	2,601,655
General and administrative expenses	1,077,299	1,704,319	4,480,070	6,145,060
Total operating expenses	2,289,282	2,657,565	9,625,855	8,968,751
Loss from Operations	-1,283,283	-1,611,167	-4,254,474	-6,585,285
Other (Expense) Income:	'	'	'	'
Interest income	274	659	1,808	6,862
Interest expense	-891,279	-19	-334,678	-399,651
Gain on settlements of accounts payable	9,038	0	188,709	190,203
Derivative expense - convertible notes payable	'	'	-61,495	0
Change in fair value of derivative liability - embedded conversion feature of Convertible Series A preferred stock	0	47,876	47,876	-2,089,744
Change in fair value of derivative liability - convertible notes payable	-681,122	0	149,398	28,244
Total Other (Expense) Income, Net	-1,563,089	48,516	-8,382	-2,264,086
Net Loss	-2,846,372	-1,562,651	-4,262,856	-8,849,371
Basic and Diluted Loss per Common Share:	'	'	'	'
Net loss per common share - basic and diluted	-2,846,372	-1,562,651	-4,262,856	-8,849,371
Preferred stock dividends - Series A	'	'	0	-191,630
Net loss available to common stockholders	'	'	($4,262,856)	($9,041,001)
Net loss per common share - basic and diluted (in dollars per share)	($0.55)	($0.43)	($0.95)	($5.08)
Weighted average number of common shares outstanding during the period - basic and diluted (in shares)	5,219,842	3,656,352	4,508,215	1,779,903

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Stockholders' Equity (Deficit) (USD $)	Total	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]	Common Stock [Member]	Subscriptions Receivable [Member]	Additional Paid in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2011	($216,468)	$405	$263	$1	$0	$39	($2,000,000)	$33,233,100	($31,450,276)
Balance (in shares) at Dec. 31, 2011	'	4,045,000	2,626,250	14,797	0	386,018	'	'	'
Conversion of Convertible Debt to Series A Preferred Stock	800,000	160	0	0	0	0	0	799,840	0
Conversion of Convertible Debt to Series A Preferred Stock (in shares)	'	1,600,000	0	0	0	0	'	'	'
Reclassification of Accrued Interest upon Conversion of Convertible Debt to Series A Preferred Stock	1,770	0	0	0	0	0	0	1,770	0
Reclassification of Derivative Liability upon Conversion of Convertible Debt to Series A Preferred Stock	1,593	0	0	0	0	0	0	1,593	0
Reclassification of Derivative Liability upon Conversion of Series A Preferred Stock to Common Stock	2,127,598	0	0	0	0	0	0	2,127,598	0
Sale of Series A Preferred Stock	3,361,000	136	0	0	0	0	2,000,000	1,360,864	0
Sale of Series A Preferred Stock (in shares)	'	1,361,000	0	0	0	0	'	'	'
Issuance of Series D Preferred Stock in connection with acquisition	500,000	0	0	0	35	0	0	499,965	0
Issuance of Series D Preferred Stock in connection with acquisition (in shares)	'	0	0	0	350,000	0	'	'	'
Payment of offering costs	-6,713	0	0	0	0	0	0	-6,713	0
Dividend arising from Preferred A beneficial conversion feature	-191,630	0	0	0	0	0	0	0	-191,630
Conversion of Series A Preferred Stock to Common Stock	0	-683	0	0	0	228	0	455	0
Conversion of Series A Preferred Stock to Common Stock (in shares)	'	-6,828,094	0	0	0	2,276,031	'	'	'
Conversion of Series B Preferred Stock to Common Stock	0	0	-55	0	0	3	0	52	0
Conversion of Series B Preferred Stock to Common Stock (in shares)	'	0	-550,000	0	0	34,931	'	'	'
Conversion of Series C Preferred Stock to Common Stock	0	0	0	-1	0	0	0	1	0
Conversion of Series C Preferred Stock to Common Stock (in shares)	'	0	0	-14,797	0	1,879	'	'	'
Warrants issued as payment of accounts payable	24,999	0	0	0	0	0	0	24,999	0
Stock based compensation	3,616,881	0	0	0	0	44	0	3,616,837	0
Stock based compensation (in shares)	'	0	0	0	0	444,223	'	'	'
Net Loss	-8,849,371	0	0	0	0	0	0	0	-8,849,371
Balance at Dec. 31, 2012	1,169,659	18	208	0	35	314	0	41,660,361	-40,491,277
Balance (in shares) at Dec. 31, 2012	'	177,906	2,076,250	0	350,000	3,143,082	'	'	'
Reclassification of Derivative Liability upon Conversion of Series A Preferred Stock to Common Stock	105,900	0	0	0	0	0	0	105,900	0
Conversion of Series A Preferred Stock to Common Stock	0	-18	0	0	0	6	0	12	0
Conversion of Series A Preferred Stock to Common Stock (in shares)	'	-177,906	0	0	0	59,302	'	'	'
Conversion of Series B Preferred Stock to Common Stock	0	0	-110	0	0	7	0	103	0
Conversion of Series B Preferred Stock to Common Stock (in shares)	'	0	-1,100,000	0	0	69,864	'	'	'
Conversion of Series D Preferred Stock to Common Stock	0	0	0	0	-35	117	0	-82	0
Conversion of Series D Preferred Stock to Common Stock (in shares)	'	0	0	0	-350,000	1,166,667	'	'	'
Reclassification of Derivative Liability upon Conversion of Convertible Notes to Common Stock	93,568	0	0	0	0	0	0	93,568	0
Cashless exercise of warrants	0	0	0	0	0	3	0	-3	0
Cashless exercise of warrants (in shares)	'	0	0	0	0	31,579	'	'	'
Conversion of Convertible Notes and Accrued Interest to Common Stock	100,541	0	0	0	0	3	'	100,538	0
Conversion of Convertible Notes and Accrued Interest to Common Stock (in shares)	'	0	0	0	0	33,514	'	'	'
Stock based compensation	2,126,875	0	0	0	0	40	0	2,126,835	0
Stock based compensation (in shares)	'	0	0	0	0	403,454	'	'	'
Net Loss	-4,262,856	0	0	0	0	0	0	0	-4,262,856
Balance at Dec. 31, 2013	($666,313)	$0	$98	$0	$0	$490	$0	$44,087,232	($44,754,133)
Balance (in shares) at Dec. 31, 2013	'	0	976,250	0	0	4,907,462	'	'	'

Consolidated_Statement_of_Chan1

Consolidated Statement of Changes in Stockholders' Equity (Deficit) [Parenthetical] (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Mar. 25, 2011
Preferred Stock, Par or Stated Value Per Share	'	'	'	$0.00
Common Stock, Par or Stated Value Per Share	$0.00	$0.00	$0.00	'
Common Stock [Member]	'	'	'	'
Common Stock, Par or Stated Value Per Share	'	$0.00	$0.00	'
Series A Preferred Stock [Member]	'	'	'	'
Preferred Stock, Par or Stated Value Per Share	'	$0.00	$0.00	'
Series B Preferred Stock [Member]	'	'	'	'
Preferred Stock, Par or Stated Value Per Share	'	$0.00	$0.00	'
Series C Preferred Stock [Member]	'	'	'	'
Preferred Stock, Par or Stated Value Per Share	$0.00	$0.00	$0.00	'
Series D Preferred Stock [Member]	'	'	'	'
Preferred Stock, Par or Stated Value Per Share	'	$0.00	$0.00	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'	'	'
Net Loss	($2,846,372)	($1,562,651)	($4,262,856)	($8,849,371)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:	'	'	'	'
Depreciation and amortization	122,554	69,075	362,993	165,018
Provision for bad debt	8,835	0	-67,432	100,299
Stock based compensation expense	316,947	938,751	2,147,763	3,586,431
Amortization of debt issue costs into interest expense	8,645	0	2,325	2,858
Amortization of debt discount into interest expense	873,872	0	308,984	395,470
Lease termination expense	'	'	9,000	0
Gain on settlement of accounts payable	-9,038	0	-188,709	-190,203
Derivative expense pertaining to convertible notes payable	'	'	61,495	0
Change in fair value of derivative liability - embedded conversion feature of convertible Series A preferred stock issuance	0	-47,876	-47,876	2,089,744
Change in fair value of derivative liability - convertible notes payable	681,122	0	-149,398	-28,244
Changes in operating assets and liabilities:	'	'	'	'
Accounts receivable	67,330	6,960	-33,838	-235,866
Other receivables	20,422	0	42,045	0
Inventory	'	'	0	16,876
Prepaid and other current assets	-33,552	-68,850	-27,991	-30,705
Other assets	'	'	0	-34,875
Accounts payable	-5,189	40,087	205,922	-214,991
Accrued expenses	40,516	37,414	-225,295	-25,932
Deferred revenues	5,041	13,834	85,004	2,309
Net Cash and Cash Equivalents Used In Operating Activities	-748,867	-573,256	-1,777,864	-3,251,182
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'	'	'
Website development costs	-143,018	-83,250	-540,942	-248,241
Cash paid to purchase property and equipment	0	-5,646	-5,645	-6,900
Net Cash and Cash Equivalents Used In Investing Activities	-143,018	-88,896	-546,587	-255,141
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'	'	'
Proceeds from sale of common stock	1,774,999	0	'	'
Cash paid for direct offering costs	-90,766	0	'	'
Principal repayments toward note payable	'	'	0	-35,000
Cash paid for debt issue costs	'	'	-10,970	0
Proceeds from sale of convertible Series A preferred stock	300,000	0	0	3,361,000
Cash paid for direct offering costs of Series A preferred stock	'	'	0	-6,713
Proceeds from convertible notes payable	'	'	1,220,000	0
Net Cash and Cash Equivalents Provided By Financing Activities	1,984,233	0	1,209,030	3,319,287
Net Increase (Decrease) in Cash and Cash Equivalents	1,092,348	-662,152	-1,115,421	-187,036
Cash and Cash Equivalents - Beginning of Period	489,166	1,604,587	1,604,587	1,791,623
Cash and Cash Equivalents - End of Period	1,581,514	942,435	489,166	1,604,587
SUPPLEMENTARY CASH FLOW INFORMATION:	'	'	'	'
Interest	0	0	0	0
Taxes	0	0	0	0
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'	'
Derivative liability reclassified to Additional Paid in Capital upon conversion of Series A preferred stock	0	105,900	105,900	2,127,598
Conversion of Convertible Notes Payable and accrued interest to common stock	841,294	0	100,541	0
Common stock issued for services	21,195	0	35,100	610,400
Derivative liability reclassified to Additional Paid in Capital upon conversion of Convertible Notes Payable	1,682,507	0	93,568	1,593
Debt discount recorded on convertible notes payable	'	'	1,182,856	0
Equipment acquired through issuance of Series D Preferred Stock in connection with acquisition - related party	'	'	0	500,000
Derivative liability arising from convertible Series A preferred stock	'	'	0	191,630
Warrants issued in connection with settlement of accounts payable	'	'	0	24,999
Conversion of Convertible Notes Payable to Series A preferred stock	'	'	0	800,000
Accrued interest on Convertible Notes Payable reclassified to Additional Paid in Capital	'	'	0	1,770
Cashless exercise of warrants	'	'	3	0
Issuance of Series C preferred stock in exchange for warrants	15	0	'	'
Series A Convertible Preferred Stock [Member]	'	'	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'	'
Conversion of preferred stock into common stock	0	18	18	683
Series B Convertible Preferred Stock [Member]	'	'	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'	'
Conversion of preferred stock into common stock	3	110	110	55
Series C Convertible Preferred Stock [Member]	'	'	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'	'
Conversion of preferred stock into common stock	'	'	0	1
Series D Convertible Preferred Stock [Member]	'	'	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'	'
Conversion of preferred stock into common stock	0	32	35	0
Series E Convertible Preferred Stock [Member]	'	'	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'	'
Conversion of Convertible Notes Payable and accrued interest to common stock	$309,698	'	'	'

Organization_and_Business

Organization and Business	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'	'
	Note 1 - Organization and Business	Note 1 – Organization and Business
	uSell.com, Inc., through our wholly-owned subsidiaries (collectively, “uSell,” “Company,” “we,” “us,” and/or “our”), is a technology based company focused on creating an online marketplace where sellers can sell small consumer electronics to professional buyers using a free, web-based platform. Through participation in the uSell marketplace, our buyers can acquire high volumes of inventory in a cost effective manner, while minimizing the investment and risk associated with creating and running their own branded advertising campaigns.	usell.com, Inc., through our wholly-owned subsidiaries (collectively, “usell,” “Company,” “we,” “us,” and/or “our”), is a reCommerce marketplace that helps Consumers monetize household items, such as small consumer electronics, that they are no longer using.
	We utilize consumer oriented advertising efforts, such as direct response television commercials, and various forms of Internet advertising to attract sellers to our website. We facilitate transactions by developing technology and logistics systems that seamlessly move product from sellers’ homes to buyers’ warehouses. We also provide our buyers with value added services, such as shipping kit fulfillments, check processing and analytics.	From the inception of our business in 2008 through 2010, substantially all of our revenue came from the procurement, aggregation and resale of precious metals. In mid-2010, we diversified our business by introducing a service, similar to our precious metals business, for cellular phones. We stopped offering to purchase precious metals in the United Kingdom and European markets during the fourth quarter of 2010 and in Canada and the United States in early 2011. By mid-2011 we further adapted our business strategy and stopped offering to purchase cellular phones directly, although through the end of 2012 we continued to service packs coming in from prior precious metals and cellular phone advertising campaigns.
	Reverse Stock Split	We utilize consumer oriented advertising efforts, such as direct response television commercials and various forms of internet advertising, to attract individuals to our website. Our services are free for Consumers and we partner with electronics buying companies to offer them a cost-efficient customer acquisition model.
	On January 21, 2014, we effected a 1-for-15 reverse stock split of our common stock (“Reverse Split”). As a result of the Reverse Split, every fifteen shares of our common stock were combined into one share of common stock. Immediately after the January 21, 2014 effective date, we had 4,907,462 shares of common stock outstanding. All share and per share amounts have been retroactively restated to reflect the Reverse Split. The authorized number of shares of our common stock and the par value remained the same. The Reverse Split did not affect the shares of preferred stock outstanding, however it did affect the number of common stock shares issuable to holders upon conversion.	Reverse Stock Split
		On January 21, 2014, we effected a 1-for-15 reverse stock split of our common stock (“Reverse Split”). As a result of the Reverse Split, every fifteen shares of our common stock was combined into one share of common stock. Immediately after the January 21, 2014 effective date, we had 4,907,462 shares of common stock outstanding. All share and per share amounts have been retroactively restated to reflect the Reverse Split. The authorized number of shares of our common stock and the par value remained the same. The Reverse Split did not affect the shares of preferred stock outstanding, however it did affect the number of common stock shares issuable to holders upon conversion.

Going_Concern

Going Concern	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Liquidity Risks and Managements Plans [Abstract]	'	'
Liquidity Disclosures [Text Block]	'	'
	Note 2 – Going Concern	Note 2 – Going Concern
	As reflected in the accompanying financial statements, the Company had a net loss of approximately $2,846,000 and net cash and cash equivalents used in operations of approximately $749,000 for the three months ended March 31, 2014. The Company has an accumulated deficit of approximately $47,601,000 and working capital of approximately $770,000 at March 31, 2014. The Company does not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of debt and equity securities. These factors raise substantial doubt about the Company’s ability to continue as a going concern.	As reflected in the accompanying consolidated financial statements, the Company had a net loss of approximately $4,263,000 and net cash and cash equivalents used in operations of approximately $1,778,000 for the year ended December 31, 2013. The Company has an accumulated deficit of approximately $44,754,000 and a working capital deficit of approximately $1,269,000 at December 31, 2013. The Company does not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of debt and equity securities. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.  These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent on management's plans, which include further implementation of its business plan and continuing to raise funds through debt and/or equity raises.	The ability of the Company to continue as a going concern is dependent on management's plans, which include further implementation of its business plan and continuing to raise funds through debt and/or equity.
	As discussed in Note 11, the Company recently filed a registration statement in connection with a primary offering of at least $10 million in gross proceeds its securities. Assuming the Company closes this offering, management expects that the going concern treatment will no longer be relevant, although no assurances can be given.	The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These  consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Significant_Accounting_Policie

Significant Accounting Policies	3 Months Ended											12 Months Ended
	Mar. 31, 2014											Dec. 31, 2013
Accounting Policies [Abstract]	'											'
Significant Accounting Policies [Text Block]	'											'
	Note 3 - Significant Accounting Policies											Note 3 – Significant Accounting Policies
	Basis of Presentation											Basis of Presentation and Principals of Consolidation
	The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is our opinion, however, that the accompanying unaudited interim condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.											The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
	The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013 as filed with the SEC, which contains the audited financial statements and notes thereto, together with Management’s Discussion and Analysis, for the years ended December 31, 2013 and 2012. The financial information as of December 31, 2013 is derived from the audited financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2013.  The interim results for the three months ended March 31, 2014 are not necessarily indicative of the results to be expected for the year ending December 31, 2014 or for any future interim periods.											Use of Estimates
	Principles of Consolidation											The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	The accompanying unaudited interim condensed consolidated financial statements include the accounts of uSell and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
												Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.
	Use of Estimates
												Reclassification
	The preparation of unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
												We have reclassified certain prior period amounts to conform to the current period presentation. These reclassifications have no effect on the financial position or on the results of operations or cash flows for the periods presented.
	Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited interim condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.
												Cash and Cash Equivalents
	Cash and Cash Equivalents
												All highly liquid investments with an original maturity of 90 days or less when purchased are considered to be cash equivalents. Cash equivalents are stated at cost, which approximates market value. Cash equivalents generally consist of money market accounts.
	All highly liquid investments with an original maturity of 90 days or less when purchased are considered to be cash equivalents. Cash equivalents are stated at cost, which approximates market value. Cash equivalents generally consist of money market accounts.
												We minimize credit risk associated with cash by periodically evaluating the credit quality of our primary financial institutions. At times, our cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit. At December 31, 2013 and 2012, our deposits exceeded the FDIC limit by approximately $187,000 and $1.4 million, respectively.
	We minimize credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. At times, our cash may be uninsured or exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit.
												Accounts Receivable and Other Receivables
	Accounts Receivable and Other Receivables
												Accounts receivable and other receivables represent obligations from our customers. We periodically evaluate the collectability of our accounts receivable and other receivables and consider the need to record an allowance for doubtful accounts based upon historical collection experience and specific information. Actual amounts could vary from the recorded estimates. Our allowance for doubtful accounts was $3,500 and $100,299 at December 31, 2013 and 2012, respectively.
	Accounts receivable and other receivables represent obligations from our buyers. We periodically evaluate the collectability of our accounts receivable and other receivables and consider the need to record an allowance for doubtful accounts based upon historical collection experience and specific information. Actual amounts could vary from the recorded estimates. Our allowance for doubtful accounts was $12,335 and $3,500 at March 31, 2014 and December 31, 2013, respectively.
												Debt Issue Costs
	Intangible Assets
												Direct costs incurred in connection with issuing debt securities or obtaining debt or other credit arrangements are recorded as debt issue costs and are amortized as interest expense over the term of the related debt.
	Our intangible assets pertain to capitalized software costs and our website domain address. We capitalize costs related to software developed or obtained for internal use when management commits to funding the project, the project completes the preliminary project stage and the software will be used to perform the function intended. Capitalization of such costs ceases when the project is substantially complete and ready for its intended use.
												Property and Equipment
	We periodically review the carrying values of our long-lived assets when events or changes in circumstances indicate that it is more likely than not that their carrying values may exceed their fair values, and record an impairment charge when considered necessary. When circumstances indicate that an impairment of value may have occurred, we test such assets for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of such assets and their eventual disposition to their carrying amounts. If the undiscounted future cash flows are less that the carrying amount of the asset, an impairment loss, measured as the excess of the carrying amount of the asset over its estimated fair value, is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.
												Property and equipment represent costs associated with leasehold improvements, software, and computer and office equipment. Property and equipment is stated at cost. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets.
	Convertible Instruments
												Intangible Assets
	We review all of our convertible instruments for the existence of an embedded conversion feature which may require bifurcation, if certain criteria are met. These criteria include circumstances in which:
												Our intangible assets pertain to capitalized software costs and our website domain address. We capitalize costs related to software developed or obtained for internal use when management commits to funding the project, the project completes the preliminary project stage and the software will be used to perform the function intended. Capitalization of such costs ceases when the project is substantially complete and ready for its intended use.
		a)	The economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,
												We periodically review the carrying values of our long-lived assets when events or changes in circumstances indicate that it is more likely than not that their carrying values may exceed their fair values, and record an impairment charge when considered necessary. When circumstances indicate that an impairment of value may have occurred, we test such assets for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of such assets and their eventual disposition to their carrying amounts. If the undiscounted future cash flows are less that the carrying amount of the asset, an impairment loss, measured as the excess of the carrying amount of the asset over its estimated fair value, is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.
		b)	The hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable GAAP with changes in fair value reported in earnings as they occur, and
		c)	A separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for when the host instrument is deemed to be conventional).									Convertible Instruments
	A bifurcated derivative financial instrument may be required to be recorded at fair value and adjusted to market at each reporting period end date. In addition, we may be required to classify certain stock equivalents issued in connection with the underlying debt instrument as derivative liabilities.											We review all of our convertible instruments for the existence of an embedded conversion feature which may require bifurcation, if certain criteria are met. These criteria include circumstances in which:
	For convertible instruments that we have determined should not be bifurcated from their host instruments, we record discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. Also when necessary, we record deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the financing transaction and the effective conversion price embedded in the preferred shares.												a)	The economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,
	Finally, if necessary, we will determine the existence of liquidated damage provisions. Liquidated damage provisions are not marked to market, but evaluated based upon the probability that a related liability should be recorded.												b)	The hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable GAAP with changes in fair value reported in earnings as they occur, and
	Common Stock Purchase Warrants and Derivative Financial Instruments												c)	A separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for when the host instrument is deemed to be conventional).
	We review any common stock purchase warrants and other freestanding derivative financial instruments at each balance sheet date and classify them on our balance sheet as:											A bifurcated derivative financial instrument may be required to be recorded at fair value and adjusted to market at each reporting period end date. In addition, we may be required to classify certain stock equivalents issued in connection with the underlying debt instrument as derivative liabilities.
		a)	Equity if they (i) require physical settlement or net-share settlement, or (ii) gives us a choice of net-cash settlement or settlement in our own shares (physical settlement or net-share settlement), or									For convertible instruments that we have determined should not be bifurcated from their host instruments, we record discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. Also when necessary, we record deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the financing transaction and the effective conversion price embedded in the preferred shares.
		b)	Assets or liabilities if they (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).									Finally, if necessary, we will determine the existence of liquidated damage provisions. Liquidated damage provisions are not marked to market, but evaluated based upon the probability that a related liability should be recorded.
	We assess classification of our common stock purchase warrants and other freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.											Common Stock Purchase Warrants and Derivative Financial Instruments
	Revenue Recognition											We review any common stock purchase warrants and other freestanding derivative financial instruments at each balance sheet date and classify them on our balance sheet as:
	Revenue is recognized when all of the following conditions exist: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured.
													a)	Equity if they (i) require physical settlement or net-share settlement, or (ii) gives us a choice of net-cash settlement or settlement in our own shares (physical settlement or net-share settlement), or
	Seller Electronics Referrals
													b)	Assets or liabilities if they (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
	Sellers responding to our advertising campaigns go to our website where they can search for the items they wish to sell using a streamlined point and click interface. Once they have identified their device, they are asked a single question to describe the condition of the device. At this point, they are presented with the “best match,” or uSell’s recommended offer from one of our buyers. We offer this recommendation based on both the price offered by the buyer relative to other buyers and the quality of ratings of the buyer relative to other buyers. The seller may choose to view a larger list of offers from all buyers interested in purchasing their device. During 2013, and into 2014, we earned up front “lead fees” from buyers when sellers accepted offers on our website and filled out a form to request a free shipping kit. This fee was received regardless of whether the sellers ultimately sent in their devices to the buyers. We recognized revenue upon online acceptance of the buyer’s offer by the seller. We record payments received from buyers in advance of offer acceptance as deferred revenue at the time payment is received.
												We assess classification of our common stock purchase warrants and other freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
	During 2013, our buyers paid fees based on the demand for the individual item which the seller was seeking to sell. Fees were not based on the value of the item sold. For instance, an iPhone might have had a higher fee than an Android, even if that particular Android had a higher offer price to the seller.
	Beginning in February 2014, we started a transition of our business model, which was phased in over the subsequent six weeks. Under the new model, buyers pay us a commission only when they pay the seller for a received device and we recognize revenue upon payment to the seller.											Revenue Recognition
	Fulfillment Revenue											Revenue is recognized when all of the following conditions exist: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured.
	In December 2012, we began to offer fulfillment services on behalf of our buyers for the items sold by sellers. We act as the agent in these transactions, passing orders booked by our buyers to our fulfillment vendors, who then assemble the kits and mail them directly to the sellers. We earn a standard fee from our buyers and recognize revenue upon shipment of the kits to the sellers. We evaluated the presentation of revenue on a gross versus net basis and determined that since we perform as an agent without assuming the risks and rewards of ownership of the goods, revenue should be reported on a net basis.											Consumer Electronics Referrals
	Advertising Revenue											Consumers responding to our advertising campaigns come to our website where they search our database for the item they wish to sell. They are prompted to answer a number of questions regarding the condition of the item and which associated accessories they have, if any. Upon completion of the appraisal questions, they are presented with a listing of offers to purchase their item from our buyers. We earn a fee for providing our buyers with customers and recognize revenue upon acceptance of the buyer’s offer by the Consumer. We receive this fee regardless of whether the Consumer ultimately sends in the device. We record payments received from buyers in advance of offer acceptance as deferred revenue at the time payment is received.
	Advertising revenues primarily come from payments for text-based sponsored links and display advertisements. Generally, our advertisers pay us on a cost per click, or CPC basis, which means advertisers pay us only when someone clicks on one of their advertisements, or on a cost per thousand impression basis, or CPM. Paying on a CPM basis means that advertisers pay us based on the number of times their advertisements appear on our websites or mobile applications.											Until January 2013, all our buyers paid similar fees per referral. The Company received a higher fee for premium electronics, such as smartphones and iPhones, and a lower fee for non-premium electronics.
	Cost of Revenue											Beginning in January 2013, we changed our fee structure with our buyers. Our buyers now pay fees based on the demand for the individual item which the Consumer is seeking to sell. Fees are no longer based on the value of the item sold. All other terms of our agreements with our buyers remained the same.
	Our cost of revenue consists primarily of costs to maintain our website, including amortization expense on our technology platform software.											Fulfillment Revenue
	Advertising											In December 2012, we began to offer fulfillment services on behalf of our buyers for the items sold by Consumers. We act as the agent in these transactions, passing orders booked by our buyers to our vendors, who then assemble the kits and mail them directly to the Consumers. We earn a standard fee from our buyers and recognize revenue upon shipment of the kits to the Consumers. We evaluated the presentation of revenue on a gross versus net basis and determined that since we perform as an agent without assuming the risks and rewards of ownership of the goods, revenue should be reported on a net basis.
	Advertising costs are expensed as they are incurred and are included in sales and marketing expenses. Advertising expense amounted to $1,060,969 and $837,847 for the three months ended March 31, 2014 and 2013, respectively.											Advertising Revenue
	Share-Based Payment Arrangements											Advertising revenues primarily come from payments for text-based sponsored links and display advertisements. Generally, our advertisers pay us on a cost per click, or CPC basis, which means advertisers pay us only when someone clicks on one of their advertisements, or on a cost per thousand impression basis, or CPM. Paying on a CPM basis means that advertisers pay us based on the number of times their advertisements appear on our websites or mobile applications.
We account for stock options in accordance with Accounting Standards Codification (“ASC”) 718: Compensation - Stock Compensation (“ASC 718”). ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.											Cost of Revenue
Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense for the three months ended March 31, 2014 and 2013.											Our cost of revenue consists primarily of costs to maintain our website, including depreciation expense on technology platform software.
Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.											Advertising
Net Loss per Share											Advertising costs are expensed as they are incurred and are included in sales and marketing expenses. Advertising expense amounted to approximately $4,461,000 and $2,422,000 for the years ended December 31, 2013 and 2012, respectively.
Basic loss per share (“EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method (by using the average stock price for the period to determine the number of shares assumed to be purchased from the exercise of stock options or warrants) and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.											Share-Based Payment Arrangements
The computation of basic and diluted loss per share at March 31, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:											We account for stock options in accordance with Accounting Standards Codification (“ASC”) 718, “Compensation - Stock Compensation.” ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.
		Three Months Ended March 31,
		2014		2013							Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense in the accompanying consolidated statements of operations.
Convertible Series A Preferred Stock		100,000		-
Convertible Series B Preferred Stock		60,415		62,002							Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.
Convertible Series C Preferred Stock		146,667		-
Convertible Series D Preferred Stock		-		83,333							Income Taxes
Convertible Series E Preferred Stock		103,232		-
Unvested Restricted Stock and Restricted Stock Units		238,885		316,667							We account for income taxes in accordance with ASC Topic 740, “Income Taxes,” which requires that we recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized.
Stock Warrants		281,686		546,906
Stock Options		542,995		478,546							ASC Topic 740-20, “Income Taxes – Intraperiod Tax Allocation,” clarifies the accounting for uncertainties in income taxes recognized in accordance with ASC Topic 740-20 by prescribing guidance for the recognition, de-recognition and measurement in financial statements of income tax positions taken in previously filed tax returns or tax positions expected to be taken in tax returns, including a decision whether to file or not to file in a particular jurisdiction. ASC Topic 740-20 requires that any liability created for unrecognized tax benefits is disclosed. The application of ASC Topic 740-20 may also affect the tax bases of assets and liabilities and therefore may change or create deferred tax liabilities or assets. We would recognize interest and penalties related to unrecognized tax benefits in income tax expense.
		1,473,880		1,487,454
											Net Loss per Share
Legal Proceedings
											Basic loss per share (“EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method, and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.
From time to time, we are a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, we are not aware of any proceeding, threatened or pending, against us which, if determined adversely, would have a material effect on our business, results of operations, cash flows or financial position.
											The computation of basic and diluted loss per share for the years ended December 31, 2013 and 2012 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:
Customer Concentrations
													Years Ended December 31,
The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.													2013		2012
		Percentage of					Percentage of Accounts				Convertible Notes Payable		373,333		-
		Revenue During the					Receivable at				Convertible Series A Preferred Stock		-		59,302
		Three Months Ended									Convertible Series B Preferred Stock		62,002		131,864
		March 31,					March 31,		December 31,		Convertible Series C Preferred Stock		-		-
		2014			2013		2014		2013		Unvested restricted stock		248,941		366,667
Buyer A		14	%		22	%	-		3	%	Stock Warrants		476,270		547,922
Buyer B		11	%		20	%	18	%	14	%	Stock Options		557,413		439,611
Buyer C		10	%		11	%	-		1	%			1,717,959		1,545,366
Buyer D		5	%		-		30	%	35	%
Buyer E		3	%		-		24	%	-
Buyer F		-			-		-		17	%	Legal Proceedings
Recent Accounting Pronouncements											From time to time, we are a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, we are not aware of any proceeding, threatened or pending, against us which, if determined adversely, would have a material effect on our business, results of operations, cash flows or financial position.
In July 2013, the Financial Accounting Standards Board issued ASU, No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). ASU 2013-11 provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013, with an option for early adoption. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.											In August 2011, the Florida Attorney General (the “AG”) initiated an official investigation into whether or not we engaged in unfair trade practices in violation of its “Little FTC Act.” The investigation was due to consumer complaints. Under Florida law, the remedies included actual damages, civil penalties, and attorneys’ fees. We provided a comprehensive response to the AG demonstrating that we acted properly. In April 2012, we met with the AG to discuss the matter and address their concerns. The AG submitted a proposed settlement in which the Company would reimburse the AG $20,000 for the costs of the investigation. In March 2013, we entered into a Settlement Agreement with the AG, pursuant to which we agreed to reimburse the AG $20,000 for investigative costs and My Gold Envelope, Inc., our subsidiary, agreed not to engage in the precious metals business. The Company paid the amount owed to the AG during the year ended December 31, 2013.
											Customer and Vendor Concentrations
											The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.
													Percentage of					Percentage of Accounts
													Revenue During the					Receivable at
													Years Ended					December 31,
													December 31,
													2013			2012		2013		2012
											Buyer A		25	%		1	%	3	%	13	%
											Buyer B		18	%		17	%	14	%	9	%
											Buyer C		8	%		18	%	4	%	6	%
											Buyer D		1	%		13	%	2	%	10	%
											Buyer E		-			14	%	-		26	%
											Buyer F		-			-		35	%	-
											Buyer G		-			-		17	%	-
											Buyer H		-			4	%	-		13	%
											Recent Accounting Pronouncements
											In July 2013, the FASB ASU, No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). ASU 2013-11 provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013, with an option for early adoption. The Company intends to adopt this guidance at the beginning of our first quarter of fiscal year 2014, and does not expect the adoption of this standard will have a material impact on its financial statements.

Fair_Value

Fair Value	3 Months Ended										12 Months Ended
	Mar. 31, 2014										Dec. 31, 2013
Fair Value Disclosures [Abstract]	'										'
Fair Value Disclosures [Text Block]	'										'
	Note 4 - Fair Value										Note 4 – Fair Value
	The fair value of our financial assets and liabilities reflects our estimate of amounts that we would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of our assets and liabilities, we seek to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:										The fair value of our financial assets and liabilities reflects our estimate of amounts that we would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of our assets and liabilities, we seek to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
		Level 1:	Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.									Level 1:	Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
		Level 2:	Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.									Level 2:	Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
		Level 3:	Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.									Level 3:	Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
	The following are the major categories of assets and liabilities measured at fair value on a recurring basis at March 31, 2014 and December 31, 2013, using quoted prices in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
											The following are the major categories of liabilities measured at fair value on a recurring basis at December 31, 2013 and 2012, using quoted prices in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
			At March 31, 2014				At December 31, 2013
			Assets		Liabilities		Assets		Liabilities				At December 31,
	Level 1												2013				2012
	None		$	-	$	-	$	-	$	-				Assets		Liabilities		Assets		Liabilities
	Level 2										Level 1
	None			-		-		-		-	None		$	-	$	-	$	-	$	-
	Level 3										Level 2
	Derivative liability			-		-		-		1,001,385	None		$	-	$	-	$	-	$	-
			$	-	$	-	$	-	$	1,001,385	Level 3
											Derivative liability		$	-	$	1,001,385	$	-	$	153,776
	The following table reflects the change in fair value of our derivative liabilities for the three months ended March 31, 2014:
											The following table reflects the change in fair value of our derivative liabilities for the years ended December 31, 2013 and 2012:
	Balance at beginning of period		$	1,001,385
	Change in value of derivative liability - convertible notes			681,122									Year Ended December 31,
	Reclassification of price protection feature to additional paid in capital - convertible notes			-1,682,507									2013				2012
	Balance at end of period		$	-										Assets		Liabilities		Assets		Liabilities
	We determined the estimated fair value amounts using available market information and appropriate methodologies. However, considerable judgment is required in interpreting market data to develop the estimates of fair value. The estimates presented are not necessarily indicative of the amounts that we could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. We have based these fair value estimates on pertinent information available as of the respective balance sheet dates and have determined that, as of such dates, the carrying value of all financial instruments approximates fair value.										Balance at beginning of period		$	-	$	153,776	$	-	$	29,837
											Change in value of derivative liability - Series A preferred stock			-		-47,876		-		2,089,744
											Reclassification of beneficial conversion feature to additional paid in capital - Series A preferred stock			-		-105,900		-		-
											Derivative liability arising from Series A preferred stock			-		-		-		191,630
											Elimination of beneficial conversion feature - Series A preferred stock			-		-		-		-2,127,598
											Derivative liability arising from issuance of convertible notes payable			-		1,244,351		-		-
											Change in value of derivative liability - convertible notes			-		-149,398		-		-28,244
											Reclassification of beneficial conversion feature to additional paid in capital - convertible notes					-93,568		-		-
											Elimination of beneficial conversion feature - convertible notes			-		-		-		-1,593
											Balance at end of period		$	-	$	1,001,385	$	-	$	153,776
											We have determined the estimated fair value amounts using available market information and appropriate methodologies. However, considerable judgment is required in interpreting market data to develop the estimates of fair value. The estimates presented are not necessarily indicative of the amounts that we could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. We have based these fair value estimates on pertinent information available as of the respective balance sheet dates and have determined that, as of such dates, the carrying value of all financial instruments approximates fair value.

Other_Receivables

Other Receivables	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Other Receivables [Abstract]	'	'
Other Receivables [Text Block]	'	'
	Note 5 – Other Receivables	Note 6 – Other Receivables
	During the year ended December 31, 2013, the Company entered into two promissory notes with two buyers, whereby certain accounts receivable due to the Company were converted into promissory notes. One of the promissory notes, entered into on February 27, 2013 for $65,771, required weekly payments of $1,028, including interest, had a stated interest rate of 5% per year, and was due on June 4, 2014. The Company agreed to settle the outstanding balance with the buyer for $15,000. Accordingly, the Company recorded other receivables in the amount of $15,000 at December 31, 2013, representing the balance owed on this note. The Company received the payment on this note in January 2014. The second promissory note, entered into on February 14, 2013, as amended on May 8, 2013, requires weekly payments of $500, has no stated interest rate and is due to be repaid on July 30, 2014. Based upon the uncertainty of the collectability of this amount, the Company has recorded an allowance for doubtful accounts on the entire balance due of $8,835 as of March 31, 2014.	During the year ended December 31, 2013, the Company entered into two promissory notes with two buyers, whereby certain accounts receivable due to the Company were converted into promissory notes. One of the promissory notes, entered into on February 27, 2013 for $65,771, required weekly payments of $1,028, including interest, had a stated interest rate of 5% per year, and was due on June 4, 2014. The Company agreed to settle the outstanding balance with the buyer for $15,000. Accordingly, the Company has recorded other receivables in the amount of $15,000 at December 31, 2013, representing the balance owed on this note. The Company received the payment on this note in January 2014. The second promissory note, entered into on February 14, 2013, as amended on May 8, 2013, requires weekly payments of $500, has no stated interest rate and is due to be repaid on July 30, 2014. At December 31, 2013, the balance owed on this note is $14,257.

Acquisition

Acquisition	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	Note 5 – Acquisition
	On February 29, 2012, EcoSquid Acquisition, Inc. (“Acquisition Corp”), an entity owned predominantly by affiliates of usell, acquired Fort Knox Recycling, LLC, doing business as EcoSquid.  The purchase price was $500,000 in cash. EcoSquid owned the intellectual property that we licensed in order to implement our comparison technology platform. EcoSquid had revenue and losses during 2011 that were immaterial relative to ours for the same period.  Aside from this transaction, Acquisition Corp. had no other assets, liabilities, revenues or expenses.
	On April 24, 2012, we acquired 100% of Acquisition Corp. by issuing 350,000 shares of Series D preferred stock to the Acquisition Corp shareholders including 90,000 shares each to our then Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer, and 25,000 shares each to our Co-Chairman and another usell shareholder.
	We valued the transaction at $500,000, based on the amount of cash paid by Acquisition Corp. for the acquisition of EcoSquid. We ascribed the full $500,000 to the comparison technology platform. We used the acquisition method of accounting in connection with the acquisition of Acquisition Corp. Accordingly, we recorded the comparison technology platform as software, valued at $500,000, in intangible assets  on our consolidated balance sheets.
	We incurred $30,924 in legal expenses pertaining to this acquisition during the first quarter of 2012, which is included in our general and administrative expense for that period.
	As discussed above, Acquisition Corp had no revenue or expenses. Therefore the only difference between the actual results reported and any pro forma results, as if the transaction had occurred on January 1, 2012, would be the depreciation that would have been incurred on the comparison technology platform. The pro forma depreciation expense would not have a meaningful impact on the losses recognized in 2012. We therefore did not present any pro forma information pertaining to this acquisition. Management evaluated the acquisition and determined that it was not significant to our overall financial statements. Accordingly, an audit of Acquisition Corp. was not performed.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	Note 7 – Property and Equipment
	Property and equipment consists of the following at December 31, 2012 and 2011:
						Estimated
		2013		2012		Useful Life
	Hardware and Software	$	14,721	$	18,927	3 years
	Furniture and Fixtures		5,645		-	3 years
	Leasehold Improvements		-		4,457	*
	Office Equipment		-		3,386	3 years
			20,366		26,770
	Less: Accumulated Depreciation		-13,077		-20,264
	Property and Equipment, Net	$	7,289	$	6,506
	* The shorter of three years or the life of the lease.
	Depreciation expense on property and equipment amounted to $4,862 and $6,984 for the years ended December 31, 2013 and 2012, respectively.

Intangible_Assets

Intangible Assets	3 Months Ended							12 Months Ended
	Mar. 31, 2014							Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'							'
Intangible Assets Disclosure [Text Block]	'							'
	Note 6 – Intangible Assets							Note 8 – Intangible Assets
	Intangible assets consist of the following:							Intangible assets consist of the following:
		Capitalized		Website		Total			Capitalized		Website
		Software		Domain					Software		Domain			Total
	Gross value at March 31, 2014	$	1,460,994	$	67,752	$	1,528,746	Gross value at December 31, 2013	$	1,317,976	$	67,752	$	1,385,728
	Accumulated amortization at March 31, 2014		-632,521		-67,752		-700,273	Accumulated amortization at December 31, 2013		-511,012		-67,752		-578,764
	Net value at March 31, 2014	$	828,473	$	-	$	828,473	Net value at December 31, 2013	$	806,964	$	-	$	806,964
	Gross value at December 31, 2013	$	1,317,976	$	67,752	$	1,385,728	Gross value at December 31, 2012	$	777,034	$	67,752	$	844,786
	Accumulated amortization at December 31, 2013		-511,012		-67,752		-578,764	Accumulated amortization at December 31, 2012		-155,103		-65,530		-220,633
	Net value at December 31, 2013	$	806,964	$	-	$	806,964	Net value at December 31, 2012	$	621,931	$	2,222	$	624,153
	Our intangible assets are amortized on a straight-line basis over their estimated useful lives of two to three years. Amortization expense amounted to $121,509 and $67,785 for the three months ended March 31, 2014 and 2013, respectively.							Our intangible assets are amortized on a straight-line basis over their estimated useful lives of two to three years. Amortization expense amounted to $358,131 and $158,034 for the years ended December 31, 2013 and 2012, respectively.
	Future annual estimated amortization expense is summarized as follows:							Future annual estimated amortization expense is summarized as follows:
	Years ending December 31,							Years ending December 31,
	2014 (remaining nine months)	$	396,278					2014	$	452,223
	2015		335,705					2015		301,681
	2016		90,119					2016		53,060
	2017		6,371						$	806,964
		$	828,473

Convertible_Notes

Convertible Notes	3 Months Ended			12 Months Ended
	Mar. 31, 2014			Dec. 31, 2013
Debt Disclosure [Abstract]	'			'
Debt Disclosure [Text Block]	'			'
	Note 7 – Convertible Notes			Note 9 – Debt
	During the year ended December 31, 2013, we borrowed $1,220,000 and issued convertible notes payable (the “Convertible Notes”) which we used for working capital purposes. The Convertible Notes were convertible at $3.00 per share, after giving effect to the Reverse Split as defined in Note 1, due two years from the date of the investment and bore interest of 5% per annum payable in common stock upon maturity or conversion. The Convertible Notes automatically converted if the Company consummated (i) a financing of at least $1 million in which it issued common stock or common stock equivalents for a price greater than $3.75 per share or (ii) a change of control transaction whereby a majority of the Company’s outstanding voting stock was sold or there was a sale of substantially all of the Company’s assets, or (iii) the closing price of the Company’s common stock was more than $4.50 for 10 consecutive trading days. Additionally, investors had price protection on future non-exempted issuances at a price lower than $3.00 per share of common stock or common stock equivalent.			2011 Convertible Notes Payable
	At the time of the issuances, we determined that the price protection feature on the Convertible Notes constituted a derivative liability and estimated the fair value of such liability to be $1,244,351using the Black-Scholes option pricing model. We recorded the fair value of the liability of $1,244,351 as a derivative liability since the price protection feature of the Convertible Notes represented a variable conversion feature. Of this amount, we recorded $1,182,856 as a discount to the Convertible Notes and $61,495 as derivative expense.			During 2011, we borrowed $800,000 and issued convertible notes payable (the “2011 Convertible Notes”) which we used for working capital purposes.
	During the year ended December 31, 2013, we issued 33,514 shares of our common stock in connection with the conversion of $100,000 of Convertible Notes, along with accrued interest of $541.			The 2011 Convertible Notes had a one-year term, an annual interest rate of approximately 0.5%, and, following a qualified financing transaction involving common stock or common stock equivalents in which we received gross proceeds in excess of $500,000 (“Future Financing”), became convertible into our common stock at 50% of the lower of (a) the price per share of common stock, or (ii) the exercise or conversion price of any common stock equivalents used in the financing transaction.
	In February 2014, holders of $820,000 Convertible Notes converted their principal, plus accrued interest of $21,294, into 280,427 shares of common stock. In addition, in February 2014, a holder of a $300,000 Convertible Note converted his note, plus accrued interest of $9,698, into 103,232 shares of newly designated Series E Preferred Stock (see Note 8). On the date of conversion, we determined the fair value of the derivative liability to be $1,682,507 using the Black-Scholes option pricing model with the following assumptions:			In addition, following the Future Financing, holders of the 2011 Convertible Notes were also entitled to receive a number of warrants to purchase our common stock equal to the number of shares they may receive as a result of the conversion described above. The warrants are exercisable for five-years and are exercisable at $3.00 per share. There were no offering costs associated with this transaction.
	Risk-free interest rate	0.22	%	We evaluated the conversion feature embedded in the 2011 Convertible Notes to determine whether such conversion feature should be bifurcated from its host instrument and accounted for as a freestanding derivative. We determined that since the exercise price of the convertible debt contained a variable conversion feature, such conversion feature should be bifurcated from its host instrument and accounted for as a freestanding derivative. We recorded the value of the conversion feature to a discount and amortized the discount to interest expense over the contracted term of the 2011 Convertible Notes. During the year ended December 31, 2012, we amortized $389,583 to interest expense pertaining to the discount.
	Expected dividend yield	0	%
	Expected volatility	239.41	%	A Future Financing closed and on January 27, 2012, the 2011 Convertible Notes were converted into 1,600,000 shares of our 2011 Series A PS (as defined in Note 11) and we issued 533,333 warrants to purchase our common stock, after giving effect to the Reverse Split as defined in Note 1, with an exercise price of $3.00 per share.
	Expected term	1.35 – 1.77 years
	We recorded an expense of $681,122 during the three months ended March 31, 2014, representing the net change in the fair value of the derivative liability pertaining to the Convertible Notes through the date of conversion and, as the derivative liability is eliminated upon conversion, recorded $1,682,507 as additional paid in capital.			On January 27, 2012, we determined that the fair value of the derivative liability pertaining to the 2011 Convertible Notes was $1,593 based on the following weighted average variables:
	We evaluated the conversion of the $300,000 Convertible Note into the Series E Preferred Stock using the applicable guidance in ASC 470-20, “Debt with Conversion and Other Options,” whereby if a convertible instrument is converted to equity securities of the debtor pursuant to an inducement offer, the debtor shall recognize an expense equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms. No gain or loss was recognized by the Company upon the conversion of the Convertible Notes into the Series E Preferred Stock since the fair value of the securities transferred was determined to be equal to the fair value of the securities issuable pursuant to the original conversion terms.			Expected dividends	0	%
				Expected volatility	189.81	%
	The discount of $1,182,856 was being accreted to non-cash interest expense over the contractual term of the Convertible Notes. During the three months ended March 31, 2014, accretion of the remaining discount amounted to $873,872. Contractual interest expense on the Convertible Notes amounted to $8,745 for the three months ended March 31, 2014.			Expected term	5 months
				Risk free interest rate	0.07	%
	The Company incurred fees associated with the closing of the Convertible Notes of $10,970. These amounts were recorded as other assets and were being amortized to interest expense over the contractual term of the Convertible Notes. During the three months ended March 31, 2014, accretion of the fees amounted to $8,645.
				We recorded a gain of $28,244 during the year ended December 31, 2012, representing the net change in the fair value of the derivative liability pertaining to the 2011 Convertible Notes and, as the derivative liability is eliminated upon conversion, recorded the remaining $1,593 as additional paid in capital.
	At March 31, 2014, all Convertible Notes have been converted and, as such, no balances remain outstanding.
				2013 Convertible Notes Payable
				During the year ended December 31, 2013, we borrowed $1,220,000 and issued convertible notes payable (the “2013 Convertible Notes”) which we used for working capital purposes. The 2013 Convertible Notes were convertible at $3.00 per share, after giving effect to the Reverse Split as defined in Note 1, due two years from the date of the investment and bore interest of 5% per annum payable in common stock upon maturity or conversion. The 2013 Convertible Notes automatically converted if the Company consummated (i) a financing of at least $1 million in which it issued common stock or common stock equivalents for a price greater than $3.75 per share or (ii) a change of control transaction whereby a majority of the Company’s outstanding voting stock was sold or there was a sale of substantially all of the Company’s assets, or (iii) the closing price of the Company’s common stock was more than $4.50 for 10 consecutive trading days. Additionally, investors received price protection on future non-exempted issuances at a price lower than $3.00 per share of common stock or common stock equivalent.
				At the time of the issuances, we determined that the price protection feature on the 2013 Convertible Notes constituted a derivative liability and estimated the fair value of such liability to be $1,244,351 using the Black-Scholes option pricing model using the following weighted average assumptions:
				Risk-free interest rate	0.28 – 0.40	%
				Expected dividend yield	0	%
				Expected volatility	261.45 – 278.90	%
				Expected life	2 years
				We recorded the fair value of the liability of $1,244,351 as a derivative liability since the price protection feature of the 2013 Convertible Notes represents a variable conversion feature. Of this amount, we recorded $1,182,856 as a discount to the 2013 Convertible Notes and $61,495 as derivative expense.
				During the year ended December 31, 2013, we issued 33,514 shares of our common stock in connection with the conversion of $100,000 of 2013 Convertible Notes, along with accrued interest of $541. On the date of conversion, we determined that the fair value of the derivative liability was $93,568 using the Black-Scholes option pricing model using the following weighted average assumptions:
				Risk-free interest rate	0.32	%
				Expected dividend yield	0	%
				Expected volatility	268.86	%
				Expected life	1.85 – 1.93 years
				We recorded a gain of $4,620 during the year ended December 31, 2013, representing the net change in the fair value of the derivative liability pertaining to the 2013 Convertible Notes and, as the derivative liability is eliminated upon conversion, recorded $93,568 as additional paid in capital.
				On December 31, 2013, we determined that the fair value of the derivative liability pertaining to the remaining 2013 Convertible Notes was $1,001,385 using the Black-Scholes option pricing model using the following weighted average assumptions:
				Risk-free interest rate	0.38	%
				Expected dividend yield	0	%
				Expected volatility	255.94	%
				Expected life	1.5 – 1.9 years
				We recorded a gain of $144,778 during the year ended December 31, 2013, representing the net change in the fair value of the derivative liability through December 31, 2013.
				The discount of $1,182,856 is being accreted to non-cash interest expense over the contractual term of the 2013 Convertible Notes. During the year ended December 31, 2013, accretion of the discount amounted to $308,984. Contractual interest expense on the 2013 Convertible Notes amounted to $22,788 for the year ended December 31, 2013.
				The Company incurred fees associated with the closing of the 2013 Convertible Notes of $10,970. These amounts have been recorded as other assets in the accompanying consolidated balance sheets, and are being amortized to interest expense over the contractual term of the 2013 Convertible Notes. During the year ended December 31, 2013, accretion of the fees amounted to $2,325.
				The components of 2013 Convertible Notes at December 31, 2013 are as follows:
							Interest			Conversion
					Balance		Rate		Maturity	Price
				Balance - December 31, 2012	$	-
				Borrowings		1,220,000	5	%	July 5, 2015 through December 3, 2015	$	0.2
				Conversions		-100,000
				Unamortized debt discount		-873,872
				Balance - December 31, 2013	$	246,128
				In February 2014, holders of $820,000 convertible notes converted their principal, plus accrued interest, into 383,659 shares of common stock and a holder of a $300,000 convertible note converted his note, plus accrued interest, into 103,232 shares of newly designated Series E Preferred Stock.

Preferred_Stock

Preferred Stock	3 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Preferred Stock [Text Block]	'
	Note 8 – Preferred Stock
	Convertible Series A Preferred Stock
	As of March 31, 2014, we have 100,000 shares of Convertible Series A Preferred Stock, with a par value of $0.0001 per share (“Series A”), outstanding.  The Series A has:
		a)	Seniority and a liquidation preference over all classes of common stock, but is subordinate to our Series B Preferred Stock;
		b)	Voting rights and powers equal to the voting rights and powers of our common stock. Each share of Series A is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		c)	A stated liquidation value of $3.00 per share;
		d)	No stated dividends; and
		e)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series A.
	On January 27, 2014, we sold 100,000 shares of Series A for proceeds of $300,000.
	Convertible Series B Preferred Stock
	As of March 31, 2014, we have 951,250 shares of Convertible Series B Preferred Stock, with a par value of $0.0001 per share, (“2010 Series B PS”) outstanding.
	The 2010 Series B PS has:
		(a)	Seniority to all classes of common and preferred stock existing or issued in the future;
		(b)	Voting rights and powers equal to the voting rights and powers of our common stock. Each share of 2010 Series B PS is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		(c)	A stated liquidation value of $1.00 per share, and a liquidation preference of the greater of $1 per share, or the amount that would be due if all 2010 Series B PS shares had been converted to common stock immediately prior to the liquidation event;
		(d)	No stated dividends;
		(e)	An option by the holder to convert each share into common shares at a rate of 0.0635 shares of common for each share of 2010 Series B PS;
	On February 4, 2014, a holder of 25,000 shares of our 2010 Series B PS converted his shares into 1,587 shares of common stock.
	Convertible Series C Preferred Stock
	On January 24, 2014, our Board authorized the issuance of up to 146,667 shares of Convertible Series C Preferred Stock (“Series C”), with a par value of $0.0001 per share.  The Series C has:
		a)	Voting rights and powers equal to the voting rights and powers of our common stock. Each share of Series C is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		b)	No stated dividends; and
		c)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series C.
	On January 27, 2014, we issued 146,667 shares of Series C in exchange for 216,667 warrants, which were cancelled.
	At March 31, 2014, there are 146,667 shares of Series C outstanding.
	Convertible Series E Preferred Stock
	On March 3, 2014, our Board authorized the issuance of up to 103,232 shares of Convertible Series E Preferred Stock (“Series E”), with a par value of $0.0001 per share.  The Series E has:
		a)	Voting rights and powers equal to the voting rights and powers of our common stock. Each share of Series C is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		b)	No stated dividends; and
		c)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series E.
	In February 2014, we issued 103,232 shares of Series E upon the conversion of a $300,000 Convertible Note, plus accrued interest of $9,698.
	At March 31, 2014, there are 103,232 shares of Series E outstanding.

Common_Stock

Common Stock	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Common Stock Disclosure [Text Block]	'
	Note 9 – Common Stock
	In February and March 2014, we sold an aggregate of 591,666 shares of our common stock, par value $0.0001, in a private placement offering for gross proceeds of $1,774,999. Palladium Capital Advisors, LLC (“Palladium”) acted as our placement agent for the offering, received a commission of $75,000 and was issued 22,083 five-year warrants exercisable at $3.00 per share. The Company estimated that the fair value of warrant was $62,241 using the Black-Scholes option pricing model. The fair value of the warrant granted to Palladium was estimated as of the date of grant using the following assumptions: (1) expected volatility of 58.9%, (2) risk-free interest rate of 1.53% and (3) expected life of five years. The Company accounted for the fair value of the warrant as a cost of the private placement offering resulting in a charge directly to stockholders’ equity. Net proceeds, after the payment of commissions and legal and other expenses of $90,766, amounted to $1,684,233.
	Shares Granted to Directors, Consultants and Employees
	On January 27, 2014, we entered into a six month joint marketing agreement with a third party consultant. Pursuant to the terms of the agreement, we are required to pay a cash fee of $40,000 for the first month of service, $30,000 for the second and third month and $10,000 per month thereafter. Additionally, we issued the consultant 30,000 fully vested shares of common stock, having a fair value of $123,744, based on the quoted closing trading price of our common stock as of the grant date. We recorded $123,744 as compensation expense pertaining to this grant during the three months ended March 31, 2014.
	On January 30, 2014, we granted 2,000 fully-vested shares of common stock, having a fair value of $6,056, based on the quoted closing trading price of our common stock as of the grant date, to an advisor for services provided. We recorded $6,056 as professional fees expense pertaining to this grant during the three months ended March 31, 2014.

StockBased_Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	Note 10 – Stock-Based Compensation
	Stock Option Grants
	During the three months ended March 31, 2014, we granted 59,332 stock options to employees for future services. These options had a fair value of $90,431 using the Black-Scholes option pricing model with the following assumptions:
	Risk-free interest rate	1.19 – 1.35	%
	Expected dividend yield	0	%
	Expected volatility	57.22 – 56.95	%
	Expected term	3.75 years
	The options are exercisable at a weighted average exercise price of $3.92 per share over a five-year term and vest over four years. We recorded $15,695 during the three months ended March 31, 2014 as compensation expense pertaining to this grant.
	Including prior period grants and the above grants, we recorded non-cash compensation expense of $114,759 and $380,801 for the three months ended March 31, 2014 and 2013, respectively, pertaining to stock option grants.
	The following table summarizes our stock option activity for the three months ended March 31, 2014:
		Number of		Weighted			Weighted		Aggregate
		Options		Average			Average		Intrinsic Value
				Exercise Price			Remaining
							Contractual
							Life
							(in Years)
	Outstanding - December 31, 2013	557,413		$	4.98		4		$	5,250
	Granted	59,332			3.92
	Exercised	-			-
	Forfeited or Canceled	-73,750			3.01
	Outstanding - March 31, 2014	542,995		$	5.14		3.9		$	869,661
	Exercisable - March 31, 2014	275,296		$	6.81		3.9		$	404,577
	The following table summarizes our stock option activity for non-vested options for the three months ended March 31, 2014:
		Number of			Weighted
		Options			Average
					Grant Date
					Fair Value
	Balance at December 31, 2013		237,040		$	4.45
	Granted		59,332			1.52
	Vested		-21,590			-6.91
	Forfeited or Canceled		-7,083			-3.01
	Balance at March 31, 2014		267,699		$	3.66
	Warrants
	The following summarizes our warrant activity for the three months ended March 31, 2014:
		Number of			Weighted			Weighted			Aggregate
		Warrants			Average			Average			Intrinsic Value
					Exercise Price			Remaining
								Contractual Life
								(in Years)
	Outstanding - December 31, 2013		476,270			3.02			3.1		$	-
	Granted		22,083			3
	Exercised		-			-
	Cancelled/Forfeited		-216,667			3
	Outstanding - March 31, 2014		281,686		$	3.04			3		$	555,224
	Exercisable - March 31, 2014		281,686		$	3.04			3		$	555,224
	As discussed in Note 9, in February 2014, in connection with the private placement offering of our common stock, we issued Palladium five-year warrants to purchase up to an aggregate of 22,083 shares of our common stock at an exercise price of $3.00 per share.
	Additionally, as discussed in Note 9, we issued 146,667 shares of Series C in exchange for 216,667 warrants, which were cancelled.
	There was no expense pertaining to warrants recorded during the three months ended March 31, 2014 and 2013.
	Restricted Stock Awards
	In June 2013, we entered into a one year investor relations agreement with a third party consultant. Pursuant to the terms of the agreement, we are required to pay a monthly cash fee of $3,000 and issued 18,000 shares of our common stock, with 4,500 shares vesting on a quarterly basis, beginning on the effective date of June 10, 2013. During the three months ended March 31, 2014, the final tranche of 4,500 shares, having a fair value of $21,195, based on the quoted closing trading price of our common stock as of the grant date, vested. This amount has been recorded as a prepaid expense and is being amortized over the remaining service term. We recorded $13,095 as professional fees expense pertaining to this grant during the three months ended March 31, 2014.
	On October 18, 2013, we granted an aggregate of 66,666 shares of restricted common stock to two of our advisors for future services to be provided. The restricted stock vests quarterly over a three year period with the first vesting date being December 31, 2013, subject to continued service on each applicable vesting date. Additionally, the restricted stock will automatically vest under certain circumstances including in the event of a change of control of the Company. During the three months ended March 31, 2014, 5,556 shares, having a fair value of $27,668, based on the quoted closing trading price of our common stock as of the grant date, vested. Accordingly, we recorded $27,668 as compensation expense pertaining to the vested portion of this grant during the three months ended March 31, 2014.
	Total unrecognized compensation expense related to unvested stock awards and unvested restricted stock units at March 31, 2014 amounts to $597,454 and is expected to be recognized over a weighted average period of 4.2 years.
	A summary of the restricted stock award activity for the three months ended March 31, 2014 is as follows:
		Number of
		Shares
	Unvested Outstanding at December 31, 2013		248,941
	Granted		32,000
	Vested		-42,056
	Unvested Outstanding at March 31, 2014		238,885

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	Note 10 – Commitments and Contingencies
	Resignation of Officer
	In October 2013, Mr. Sergio Zyman resigned as Chairman of the Board of Directors, a director and as Chief Executive Officer of the Company. In connection with his resignation as Chairman and Chief Executive Officer, 216,667 shares of unvested  common stock were forfeited. In addition, Mr. Zyman also forfeited his 66,666 fully vested options.  On October 16, 2013, Mr. Michael Brauser was appointed Chairman of the Board of the Company, replacing Mr. Zyman. Additionally, on the same date, Mr. Daniel Brauser, the Company’s President, was appointed interim Chief Executive Officer and replaced Mr. Zyman.
	Operating Leases
	We lease space for operations, sales, customer support and corporate purposes under a lease agreement that expires in August 2015. The lease contains provisions requiring us to pay maintenance, property taxes and insurance. For the years ended December 31, 2013 and 2012, the aggregate rent expense for all operating leases was approximately $95,000 and $51,000, respectively. Future minimum commitments are as follows:
	For the Year Ended December 31,
	2014	$	77,625
	2015		51,750
		$	129,375

Stockholders_Equity_Deficit

Stockholders' Equity (Deficit)

12 Months Ended

Dec. 31, 2013

Stockholders' Equity Note [Abstract]

'

Stockholders Equity Note Disclosure [Text Block]

'

Note 11 – Stockholders’ Equity (Deficit)

Convertible Series A Preferred Stock

On November 18, 2011, our Board authorized the sale of up to 10,000,000 shares of Convertible Series A Preferred Stock (“2011 Series A PS”), with a par value of $0.0001 per share. The 2011 Series A PS had:

a)

Seniority and a liquidation preference over all classes of common stock, but subordinate to our Series B Preferred Stock and Series C Preferred Stock;

b)

Voting rights and powers equal to the voting rights and powers of our common stock. Each share of 2011 Series A PS was entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;

c)

A stated liquidation value of $1 per share;

d)

No stated dividends; and

e)

Automatic conversion (subject to blocking provisions for certain significant shareholders) into common shares upon the consummation of the 1-for-52.4846 reverse stock split effected on June 8, 2012 at a rate of five common shares for each share of 2011 Series A PS. Shares of the 2011 Series A PS were not subject to the reverse split.

During 2012, we sold 1,361,000 shares of our 2011 Series A PS for gross proceeds of $1,361,000 and converted $800,000 of our convertible notes payable into 1,600,000 shares of 2011 Series A PS (Note 9). In connection with the sale of the 2011 Series A PS, we incurred direct offering costs totaling $27,282. After the Reverse Split, and without giving effect to certain blocker provisions limiting conversions, the 7,006,000 outstanding shares of 2011 Series A PS would convert into 2,335,333 shares, or approximately 86%, of our then outstanding common stock.

In January 2012, we offered price protection to the purchasers of the 2011 Series A PS (“Purchasers”) whereby if we sold securities, including options, warrants, or convertible securities, with the purpose of raising capital from investors, at a price, or with an exercise or conversion price, of less than the 2011 Series A PS conversion price (as defined in the Amended and Restated Certificate of Designation filed with the Secretary of the State of Delaware on November 29, 2011), then:

a)

the conversion price of any outstanding 2011 Series A PS would automatically be reduced to the sale price, or the exercise or conversion price, or

b)

if converted, we would issue additional shares of our common stock to the Purchasers respecting the common shares still owned by the Purchasers as a result of their conversion of the 2011 Series A PS, such that the average per share purchase price of these common shares then owned by the Purchasers would equal the lower price offered in the subsequent sale of securities.

At that time, we determined that the price protection feature on the 7,006,000 shares of 2011 Series A PS constituted a derivative liability and estimated the fair value of such liability to be $191,630 using the Black-Scholes option pricing model using the following weighted average assumptions:

Expected dividends

0

%

Expected volatility

190.40% - 191.75

%

Expected term

5 years

Risk free interest rate

0.71% - 0.88

%

We recorded the fair value of the liability of $191,630 as a preferred stock dividend since the price protection feature of the 2011 Series A PS represents a variable conversion feature.

As a result of our 1-for-52.4846 reverse stock split on June 8, 2012 and, subject to certain blocker agreements limiting the common stock ownership percentages of certain investors to 9.99% of the outstanding common stock, the 2011 Series A PS automatically converted into common stock. Accordingly, 5,356,000 shares of 2011 Series A PS were converted into 1,785,333 shares of our common stock. We reclassified $134,664 of derivative liability, representing the fair value of the 5,356,000 shares of 2011 Series A PS that converted, to additional paid in capital.

During 2012, shareholders converted an additional 1,472,094 shares of 2011 Series A PS into 490,698 shares of our common stock. Accordingly, we reclassified $1,992,934 of derivative liability, representing the fair value of the 1,472,094 shares of 2011 Series A PS that converted, to additional paid in capital.

On December 31, 2012, we determined that the fair value of the derivative liability pertaining to the 177,906 outstanding shares of 2011 Series A PS was $153,776 using the Black-Scholes option pricing model based on the following weighted average variables:

Expected dividends

0

%

Expected volatility

209.62

%

Expected term

4 years

Risk free interest rate

0.72

%

We recorded a loss of $2,089,744, representing the net change in the fair value of the derivative liability pertaining to the 2011 Series A PS during the year ended December 31, 2012.

During March 2013, as a result of the conversion of our 2012 Series D PS (discussed below), the remaining 177,906 outstanding shares of our 2011 Series A PS automatically converted (as a result of no longer being subject to a 9.99% conversion blocker) into 59,302 shares of our common stock, at a conversion rate of .3333 common shares for each share of Series 2011 A PS. Accordingly, we reclassified $105,900 of derivative liability, representing the fair value of the 177,906 shares of 2011 Series A PS immediately prior to the conversion, to additional paid in capital, and recorded a gain of $47,876 for the remaining derivative liability pertaining to the 2011 Series A PS during the year ended December 31, 2013.

We determined that the fair value of the derivative liability pertaining to the 177,906 shares of 2011 Series A PS immediately prior to the conversion was $105,900 using the Black-Scholes option pricing model based on the following weighted average variables:

Expected dividends

0

%

Expected volatility

214.26

%

Expected term

4 years

Risk free interest rate

0.81

%

Convertible Series B Preferred Stock

On August 3, 2010, our Board authorized the sale of up to $4,000,000 of Units in a private placement (the “August 2010 PP”), whereby each Unit consisted of 100,000 shares of Convertible Series B Preferred Stock (“2010 Series B PS”) and 3,176 warrants to purchase our common stock.

The 2010 Series B PS had:

(a)

Seniority to all classes of common and preferred stock existing or issued in the future;

(b)

Voting rights and powers equal to the voting rights and powers of our common stock. Each share of 2010 Series B PS was entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;

(c)

A stated liquidation value of $1 per share, and a liquidation preference of the greater of $1 per share, or the amount that would be due if all 2010 Series B PS shares had been converted to common stock immediately prior to the liquidation event;

(d)

No stated dividends;

(e)

An option by the holder to convert each share into common shares at a rate of 0.0635 shares of common for each share of 2010 Series B PS;

(f)

Conversion price protection whereby if, in the twelve months following the date of the filing of the amended certificate of designation with the State of Delaware (August 16, 2010), we sell any stock for a price less than $0.30 per share, then the conversion price will be adjusted to reflect the lowest price for which the shares were sold;

During 2012, holders of 550,000 shares of our 2010 Series B PS converted their shares into 34,931 shares of common stock, at a conversion rate of 0.0635 common shares for each share of 2010 Series B PS.

During 2013, holders of 1,100,000 shares of our 2010 Series B PS converted their shares into 69,864 shares of common stock, at a conversion rate of 0.0635 common shares for each share of 2010 Series B PS.

At December 31, 2013, there are 976,250 shares of 2010 Series B PS outstanding.

Convertible Series C Preferred Stock

On March 25, 2011, our Board authorized the sale of up to 1,000,000 shares of Convertible Series C Preferred Stock (“2011 Series C PS”), with a par value of $0.0001 per share. The 2011 Series C PS had:

(a)

Seniority to all classes of common stock and all preferred stock issued in the future with a liquidation preference senior to the common stock;

(b)

Voting rights and powers equal to the voting rights and powers of our common stock. Each share of 2011 Series C PS was entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;

(c)

A liquidation preference of the greater of the original issue price, or the amount that would be due if all 2011 Series C PS shares had been converted to common stock immediately prior to the liquidation event;

(d)

No stated dividends;

(e)

Automatic conversion (subject to blocking provisions for certain significant shareholders) into common shares at a rate of 0.12702 shares of common for each share of 2011 Series C PS.

On July 31, 2012, the remaining 14,797 outstanding shares of 2011 Series C PS were converted into 1,879 shares of common stock.

Series D Preferred Stock

On April 24, 2012, our Board authorized the sale of up to 350,000 shares of Series D Preferred Stock (“2012 Series D PS”), with a par value of $0.0001 per share. The 2012 Series D PS had:

a)

A liquidation preference equal to $10.00 per share;

b)

No voting rights;

c)

No stated dividends; and

d)

Were convertible into common shares at a rate of 3.33 shares of common for each share of 2012 Series D PS (see below).

During the third quarter of 2012, our Board amended the conversion rights on the 2012 Series D PS such that it became convertible immediately prior to the closing of a Combined Transaction or the occurrence of the Liquidation Event, both as defined in the Certificate of Designation, as amended.

In March 2013, the Company amended the conversion rights on its outstanding 2012 Series D PS giving its holders the option to convert their 2012 Series D PS shares at their discretion. Subsequently, holders of all 350,000 shares of 2012 Series D PS elected to convert their 2012 Series D PS into 1,166,667 shares of common stock, at a conversion rate of 3.33 common shares for each share of 2012 Series D PS.

Common Stock

We are authorized to issue 650,000,000 shares of common stock with a par value of $0.0001 per share.

Shares Granted to Directors, Consultants and Employees

During 2012, we granted 300,000 fully vested shares of common stock, having a fair value of $1,487,500 based on the quoted closing trading price of our common stock as of the grant date, to our current and former Chairmen of the Board. The shares were issued as compensation for service on our board of directors. We recorded $1,487,500 as compensation expense pertaining to this grant during the year ended December 31, 2012.

During 2012, we granted 110,667 fully vested shares of common stock, having a fair value of $610,400 based on the quoted closing trading price of our common stock as of the grant date, to third party consultants for services to be provided over a six month to one-year period. We recorded the amount as a prepaid expense and amortized the expense over the expected remaining service term. We recorded $30,450 and $579,950 during the years ended December 31, 2013 and 2012, respectively, as compensation expense pertaining to this grant.

In connection with the 400,000 shares of restricted common stock granted to our former Chief Executive Officer, 150,000 shares and 33,333 shares of the restricted common stock were vested and issued to him during the years ended December 31, 2013 and 2012, respectively. The remaining 216,667 unvested shares were forfeited upon his resignation (see below).

During February 2013, we granted 233,333 fully vested shares of common stock, having a fair value of $437,500 based on the quoted closing trading price of our common stock as of the grant date, to our former Chief Executive Officer. We recorded $437,500 as compensation expense pertaining to this grant during the year ended December 31, 2013.

In June 2013, the Company granted 1,333 fully-vested shares of common stock, having a fair value of $4,000 based on the quoted closing trading price of our common stock as of the grant date, to a third party consultant for services provided. We recorded $4,000 as professional fees expense pertaining to this grant during the year ended December 31, 2013.

Including the above grants, we recorded non-cash compensation expense of $805,238 and $2,140,947 for the years ended December 31, 2013 and 2012, respectively, pertaining to stock grants, including restricted stock grants.

Common Stock Purchase Warrants

In January 2012, we granted 533,333 warrants to purchase our common stock to the holders of our 2011 Convertible Notes. The warrants have an exercise price of $3.00 and are exercisable for five years. The estimated fair value of these stock warrants on their date of grant was $43,042, which we estimated using the Black-Scholes option pricing model using the following assumptions:

Expected dividends

0

%

Expected volatility

189.81

%

Expected term

5 years

Risk free interest rate

0.75

%

These warrants were to be issued to the note holders upon the completion of a Future Financing. As such, we considered these warrants to be a cost of the Future Financing, the recording of which had a net effect of zero on our additional paid in capital account.

In March 2012, in connection with a settlement of an outstanding balance in our accounts payable, we issued 25,000 warrants to a third party service provider to purchase our 2011 Series A PS. In connection with the Reverse Split, these warrants were converted into warrants to purchase 8,333 shares of our common stock. The warrants have an exercise price of $3.00 and are exercisable for five years. The estimated fair value of these stock warrants on their date of grant was $25,000, which we estimated using the Black-Scholes option pricing model using the following assumptions:

Expected dividends

0

%

Expected volatility

195.66

%

Expected term

5 years

Risk free interest rate

1.06

%

The $25,000 value of these warrants was included in the calculation of our gain on the settlement of accounts payable during the year ended December 31, 2012.

There was no expense pertaining to warrants recorded during the year ended December 31, 2013.

The aggregate intrinsic value of the warrants at December 31, 2013 and 2012 was $0.

The following summarizes our warrant activity for the years ended December 31, 2013 and 2012:

Series A Preferred Stock

Common Stock

Weighted

Weighted

Weighted

Average

Weighted

Average

Average

Remaining

Average

Remaining

Number of

Exercise

Contractual Life

Number of

Exercise

Contractual Life

Warrants

Price

(in Years)

Warrants

Price

(in Years)

Outstanding - December 31, 2011

-

$

-

-

18,799

$

194.4

1.1

Granted

25,000

0.2

541,667

3

Exercised

-

-

-

-

Cancelled/Forfeited

-25,000

0.2

-12,543

243.65

Outstanding - December 31, 2012

-

$

-

-

547,922

4.05

4

Granted

-

-

-

-

Exercised

-

-

-66,667

3

Cancelled/Forfeited

-

-

-4,986

117.84

Outstanding - December 31, 2013

-

$

-

-

476,270

$

3.02

3.1

Exercisable - December 31, 2013

-

$

-

-

476,270

$

3.02

3.1

Stock Option Grants

On October 30, 2013, we amended our 2008 Equity Incentive Plan (the “Plan”) to increase the aggregate number of shares of common stock by 250,000. We are now authorized to issue 284,296 shares under the Plan. The Plan is administered by the board of directors. Under the Plan, the board of directors is authorized to grant awards to employees, consultants and any other persons to whom the Plan is applicable and to determine the number and types of such awards and the terms, conditions, vesting and other limitations applicable to each such award. The Plan provides for the issuance of both incentive stock options (“ISO’s”) and non-qualified stock options (“NQO’s”). ISO’s can only be granted to employees and NQO’s can be granted to directors, officers, employees, consultants, independent contractors and advisors.

The fair value of options is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on historical volatility of the Company’s common stock, the expected life is based on the estimated average of the life of options using the simplified method, and forfeitures are estimated on the date of grant based on certain historical data. We utilize the simplified method to determine the expected life of our options due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on our history and expectation of dividend payouts.

Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

During 2012, we granted 31,667 options to vendors for future services. The options are exercisable at a weighted average exercise price of $3.00 per share over a five to ten-year term. Of the options granted, 5,000 options vested immediately upon grant, 10,000 options vest over a six-month period and 16,667 vest over a two-year period. We recorded $19,563 and $13,070 during the years ended December 31, 2013 and 2012, respectively, as compensation expense pertaining to this grant. These options had an aggregate fair value of $48,935 using the Black-Scholes option-pricing model using the following weighted average assumptions:

Risk free interest rate

0.67% - 1.67

%

Expected dividends

0

%

Expected volatility

194.68% - 207.45

%

Expected term

5 – 10 years

During 2012, we granted 22,035 stock options to employees for future services. These options had a fair value of $65,441 using the Black-Scholes option-pricing model using the following weighted average assumptions:

Risk free interest rate

0.83% - 1.91

%

Expected dividends

0

%

Expected volatility

196.04% - 204.98

%

Expected term

5 – 10 years

The options are exercisable at a weighted average exercise price of $3.00 per share over a five to ten-year term and vest over four years. We recorded $9,158 and $11,904 during the years ended December 31, 2013 and 2012, respectively, as compensation expense pertaining to this grant.

During 2012, we granted 33,333 stock options to our former Chief Operating Officer in connection with his separation from the Company. These options had a fair value of $3,150 using the Black-Scholes option-pricing model using the following assumptions:

Risk free interest rate

1.9

%

Expected dividends

0

%

Expected volatility

189.81

%

Expected term

10 years

The options have an exercise price of $3.00 per share over a ten-year term and were completely vested at the time of the grant. We recorded $3,150 during the year ended December 31, 2012 as compensation expense pertaining to this grant.

During 2012, we granted 275,667 stock options to members of our board of directors and our executive officers for future services. These options had an aggregate fair value of $1,289,250 using the Black-Scholes option-pricing model using the following weighted average assumptions:

Risk free interest rate

0.60% - 0.69

%

Expected dividends

0

%

Expected volatility

204.30% - 205.26

%

Expected term

5 years

The options are exercisable at a weighted average exercise price of $3.00 per share over a five-year term. Of the stock options granted, 69,000 vested immediately upon grant, 66,667 vest after one-year, and 140,000 vest over a four-year period. We recorded $291,525 and $543,948 during the years ended December 31, 2013 and 2012, respectively, as compensation expense pertaining to this grant.

During 2013, we granted 144,333 stock options to employees for future services. These options had a fair value of $384,387 using the Black-Scholes option-pricing model with the following assumptions:

Risk free interest rate

0.54% - 1.37

%

Expected dividends

0

%

Expected volatility

204.36% - 219.25

%

Expected term

5 years

The options are exercisable at exercise prices ranging from $3.00 to $4.50 per share over a five-year term and vest over four years. We recorded $35,490 during the year ended December 31, 2013 as compensation expense pertaining to this grant.

Including the prior period grants and the above grants, we recorded non-cash compensation expense of $1,342,525 and $1,445,484 for the years ended December 31, 2013 and 2012, respectively.

The following table summarizes our stock option activity for the year ended December 31, 2013:

Weighted

Average

Weighted

Remaining

Average

Contractual

Number of

Exercise

Life

Aggregate

Options

Price

(in Years)

Intrinsic Value

Outstanding - December 31, 2012

439,611

$

6.15

4.8

$

-

Granted

144,333

3.04

Exercised

-

-

Forfeited or Canceled

-26,531

13.16

Outstanding - December 31, 2013

557,413

$

4.98

4

$

5,250

Exercisable - December 31, 2013

320,373

$

6.18

4

$

-

The following table summarizes our stock option activity for non-vested options for the year ended December 31, 2013:

Weighted

Average

Number of

Grant Date

Options

Fair Value

Balance at December 31, 2012

263,765

$

8.4

Granted

144,333

$

2.66

Vested

-146,243

$

-10.25

Forfeited or Canceled

-24,815

$

-13.16

Balance at December 31, 2013

237,040

$

4.45

The weighted-average grant date fair value of options granted during the years ended December 31, 2013 and 2012 was $2.66 and $3.75, respectively. Total unamortized compensation expense related to stock options at December 31, 2013 amounted to $1,002,764 and is expected to be recognized over a weighted average period of 3 years.

Restricted Stock Awards

On December 21, 2012, we granted 400,000 shares of restricted common shares to our former Chief Executive Officer. Of these shares, 33,333 were fully vested on the date of grant and the remaining shares were scheduled to vest in equal increments of 16,666 shares over a 22-month period, with the first vesting date being January 10, 2013, subject to continued employment on each applicable vesting date. The fair value of the common stock at the date of grant was $1.80 per share, based upon our closing market price on the date of grant. The aggregate grant date fair value of the award amounted to $720,000, which was to be recognized as compensation expense over the vesting period. We recorded $270,000 and $60,000 of compensation expense during the years ended December 31, 2013 and 2012, respectively, with respect to this award. On October 16, 2013, our Chief Executive Officer resigned from his position and all unvested shares were forfeited (see Note 10).

In June 2013, we entered into a one year Investor Relations agreement with a third party consultant. Pursuant to the terms of the agreement, we are required to pay a monthly cash fee of $3,000 and issued 18,000 shares of our common stock, with 4,500 shares vesting on a quarterly basis, beginning on the effective date of June 10, 2013. As of December 31, 2013, 13,500 shares, having a fair value of $35,100 based on the quoted closing trading price of our common stock as of the grant date, have vested. This amount has been recorded as a prepaid expense and is being amortized over the service term. We recorded $25,538 as professional fees expense pertaining to  this grant during the year ended December 31, 2013.

On October 18, 2013 we granted an aggregate of 66,666 shares of restricted common stock to two of our advisors for future services to be provided. The restricted stock vests quarterly over a three year period with the first vesting date being December 31, 2013, subject to continued service on each applicable vesting date. Additionally, the restricted stock will automatically vest under certain circumstances including in the event of a change of control of the Company. As of December 31, 2013, 5,556 shares, having a fair value of $16,667 based on the quoted closing trading price of our common stock as of the grant date, have vested. Accordingly, we recorded $16,667 as professional fees expense pertaining to the vested portion of this grant during the year ended December 31, 2013.

On October 31, 2013, we granted 183,331 restricted stock units (“RSUs”) to our directors. The RSUs vest annually over a five year period with the first vesting date being October 31, 2014, subject to continued service on each applicable vesting date. Additionally, the RSUs will automatically vest under certain circumstances including in the event of a change of control of the Company. The RSUs will have no voting rights or dividend rights. The fair value of the common stock at the date of grant is $3.45 per share, based upon our closing market price on the date of grant. The aggregate grant date fair value of the award amounts to $632,500, which will be recognized as compensation expense over the vesting period. We recorded $21,083 of compensation expense during the year ended December 31, 2013 with respect to this award.

Total unrecognized compensation expense related to unvested stock awards at December 31, 2013 amounts to $620,979 and is expected to be recognized over a weighted average period of 4.3 years.

A summary of the restricted stock award activity for the year ended December 31, 2013 is as follows:

Number of

Shares

Unvested Outstanding at December 31, 2012

366,667

Granted (1)

502,663

Cancelled

-216,667

Vested

-403,722

Unvested Outstanding at December 31, 2013

248,941

(1) Includes 183,331 RSUS granted, but not considered issued or outstanding until vested.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	Note 12 – Income Taxes
	We recognize deferred tax assets and liabilities for both the expected impact of differences between the financial statements and the tax basis of assets and liabilities, and for the expected future tax benefit to be derived from tax losses and tax credit carryforwards. We have established a valuation allowance to reflect the likelihood of realization of deferred tax assets.
	The domestic and foreign components of our consolidated net pre-tax loss from operations for the respective periods are as follows:
		Year ended December 31,
		2013		2012
	Domestic loss	$	-4,442,000	$	-8,849,000
	Foreign income (loss)		179,000		—
	Consolidated net loss before income tax expense	$	-4,263,000	$	-8,849,000
	The valuation allowance at December 31, 2012 was approximately $9,368,000. The net change in the valuation allowance during the year ended December 31, 2013 was an increase of approximately $1,744,000. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on consideration of these items, management has determined that enough uncertainty exists relative to the realization of the deferred income tax asset balances to warrant the application of a full valuation allowance as of December 31, 2013.
	We have a net operating loss carryforward totaling approximately $23,320,000 at December 31, 2013, expiring through 2033. There is a limitation on the amount of taxable income that can be offset by carryforwards after a change in control (generally greater than a 50% change in ownership). We are subject to examination by federal and state taxing authorities for the 2010 and subsequent tax years. Temporary differences, which give rise to a net deferred tax asset, are approximately as follows:
	Significant deferred tax assets are as follows:
		December 31,
		2013		2012
	Current deferred tax assets:
	Accrued Expenses	$	30,000	$	119,000
	Allowance for Doubtful Accounts		1,000		38,000
	Subtotal current deferred tax asset		31,000		157,000
	Non-current deferred tax assets and liabilities:
	Intangible Assets	$	27,000	$	29,000
	Fixed Assets		-123,000		-112,000
	Discount on Convertible Notes		-329,000		—
	Derivative Liability		377,000		—
	Stock Options		2,477,000		1,972,000
	Net operating loss carryover		8,652,000		7,322,000
	Subtotal non-current deferred tax asset		11,081,000		9,211,000
	Total deferred tax asset	$	11,112,000	$	9,368,000
	Less:  valuation allowance		-11,112,000		-9,368,000
	Net deferred tax assets	$	—	$	—
	The actual tax expense (benefit) differs from the expected tax expense (benefit) for the years ended December 31, 2013 and 2012 (computed by applying the U.S. Federal Corporate income tax rate of 34% to income before taxes and 5.5% for State income taxes, a blended rate of 37.63%) as follows:
		December 31,
		2013		2012
	Expected tax expense (benefit) - federal	$	-1,449,000	$	-3,009,000
	Expected tax expense (benefit) - state		-159,000		-321,000
	Foreign rate differential		-23,000		—
	Change in fair value of derivative liability - embedded conversion feature		—		776,000
	Permanent items		22,000		1,000
	True-up		-135,000		—
	Change in valuation allowance		1,744,000		2,553,000
	Actual tax expense	$	—	$	—

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	Note 13 – Related Party Transactions
	Digital Connect Solutions, Inc.
	In accordance with a Commissions Agreement, Digital Connect Solutions, Inc. (“DCS”), an entity controlled by Scott Frohman, a director, received a 25% commission on the gross profits generated by the Company from traffic generated by DCS. The commissions were paid on all cost per acquisition leads (“CPAs”) and all non-CPAs generated by the Company from DCS’s direct selling efforts. The Company paid DCS $29,691 in 2013 and $3,622 in 2014. The Commission Agreement was terminated in January 2014.

Subsequent_Events

Subsequent Events	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Subsequent Events [Abstract]	'	'
Subsequent Events [Text Block]	'	'
	Note 11 – Subsequent Events	Note 14 – Subsequent Events
	On April 10, 2014, our Board of Directors granted 150,000 Restricted Stock Units, or RSUs, to each of Daniel Brauser, our Chief Executive Officer, and Nik Raman, our Chief Operating Officer. The RSUs vest in five equal annual increments over a five-year period subject to continued employment and earlier upon a change of control as defined in the 2008 Equity Incentive Plan. Additionally, on April 10, 2014, we entered into agreements with Michael Brauser and Doug Feirstein, both directors of the Company, through which each agreed within 90 days to prematurely exercise for cash one-half of their warrants and exchange one-half for RSUs. Mr. Brauser holds 216,666 warrants and Mr. Feirstein holds 33,333 warrants, each issued on January 27, 2012 and exercisable for five years at $3.00 per share (giving effect to the reverse stock split). The RSUs will be identical to other RSUs they hold, including vesting over five years.	On January 27, 2014, we entered into a six month Joint Marketing Agreement with a third party consultant. Pursuant to the terms of the agreement, we are required to pay a cash fee of $40,000 for the first month of service, $30,000 for the second and third month of service and $10,000 per month thereafter. Additionally, we issued 30,000 shares of our common stock.
	On April 15, 2014, we filed an amendment to a registration statement on Form S-1 for the public sale of $10,000,000 of units (subject to a 15% over-allotment option), consisting of an unspecified number of shares of common stock and warrants at a public offering price to be determined. Dawson James Securities, Inc. will be acting as underwriter on a firm-commitment basis.	On January 30, 2014, we granted 2,000 shares of our common stock to an advisor for services provided in January 2014.
		On January 27, 2014, we raised $300,000 from the sale of 100,000 shares of newly designated Series A Convertible Preferred Stock (“Series A”).  The Series A shares: (i) convert into 100,000 shares of our common stock (subject to adjustment) at the option of the investor, (ii) are entitled to vote on all matters submitted to shareholders of the Company and vote on an as converted basis and (iii) have a liquidation preference.
		Additionally, on January 27, 2014, we issued this investor 146,667 shares of newly designated Series C Convertible Preferred Stock (“Series C”) in exchange for 216,667 warrants, which were cancelled.  The Series C shares (i) convert into 146,667 shares of the Company’s common stock (subject to adjustment) at the option of the investor and (ii) are entitled to vote on all matters submitted to shareholders of the Company and vote on an as converted basis.
		Both the Series A and Series C contain blockers which prevent this investor from beneficially owning more than 9.9% of the Company’s common stock.
		On February 4, 2014, a holder of 25,000 shares of our 2010 Series B PS converted his shares into 1,587 shares of common stock, at a conversion rate of 0.0635 common shares for each share of 2010 Series B PS.
		During February and March 2014, we sold 591,667 shares of our common stock in a private placement offering in exchange for $1,775,000. Palladium Capital Advisors, LLC acted as placement agent for the offering and was issued 22,083 five-year warrants exercisable at $3.00 per share. Net proceeds to the Company were $1,700,000.
		In February 2014, holders of $820,000 convertible notes converted their principal, plus accrued interest, into 383,659 shares of common stock.
		In February 2014, the holder of a $300,000 convertible note converted his note plus accrued interest into 103,232 shares of newly designated Series E Preferred Stock (“Series E”). The Series E shares (i) convert into 103,232 shares of our common stock (subject to adjustment) at the option of the holder; (ii) are entitled to vote on all matters submitted to shareholders of the Company and vote on an as converted basis (subject to a blocker) and (iii) contain a blocker which prevents the holder from beneficially owning more than 9.9% of the Company’s common stock..

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)

3 Months Ended

12 Months Ended

Mar. 31, 2014

Dec. 31, 2013

Accounting Policies [Abstract]

'

'

Basis Of Accounting Policy [Policy Text Block]

'

'

Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is our opinion, however, that the accompanying unaudited interim condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013 as filed with the SEC, which contains the audited financial statements and notes thereto, together with Management’s Discussion and Analysis, for the years ended December 31, 2013 and 2012. The financial information as of December 31, 2013 is derived from the audited financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2013.  The interim results for the three months ended March 31, 2014 are not necessarily indicative of the results to be expected for the year ending December 31, 2014 or for any future interim periods.

Consolidation, Policy [Policy Text Block]

'

'

Principles of Consolidation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of uSell and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Basis Of Accounting And Consolidation, Policy [Policy Text Block]

'

'

Basis of Presentation and Principals of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation

Use Of Estimates, Policy [Policy Text Block]

'

'

Use of Estimates

Use of Estimates

The preparation of unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited interim condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

Reclassification, Policy [Policy Text Block]

'

'

Reclassification

We have reclassified certain prior period amounts to conform to the current period presentation. These reclassifications have no effect on the financial position or on the results of operations or cash flows for the periods presented.

Cash and Cash Equivalents, Policy [Policy Text Block]

'

'

Cash and Cash Equivalents

Cash and Cash Equivalents

All highly liquid investments with an original maturity of 90 days or less when purchased are considered to be cash equivalents. Cash equivalents are stated at cost, which approximates market value. Cash equivalents generally consist of money market accounts.

All highly liquid investments with an original maturity of 90 days or less when purchased are considered to be cash equivalents. Cash equivalents are stated at cost, which approximates market value. Cash equivalents generally consist of money market accounts.

We minimize credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. At times, our cash may be uninsured or exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit.

We minimize credit risk associated with cash by periodically evaluating the credit quality of our primary financial institutions. At times, our cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit. At December 31, 2013 and 2012, our deposits exceeded the FDIC limit by approximately $187,000 and $1.4 million, respectively.

Trade And Other Accounts Receivable [Policy Text Block]

'

'

Accounts Receivable and Other Receivables

Accounts Receivable and Other Receivables

Accounts receivable and other receivables represent obligations from our buyers. We periodically evaluate the collectability of our accounts receivable and other receivables and consider the need to record an allowance for doubtful accounts based upon historical collection experience and specific information. Actual amounts could vary from the recorded estimates. Our allowance for doubtful accounts was $12,335 and $3,500 at March 31, 2014 and December 31, 2013, respectively.

Accounts receivable and other receivables represent obligations from our customers. We periodically evaluate the collectability of our accounts receivable and other receivables and consider the need to record an allowance for doubtful accounts based upon historical collection experience and specific information. Actual amounts could vary from the recorded estimates. Our allowance for doubtful accounts was $3,500 and $100,299 at December 31, 2013 and 2012, respectively.

Debt, Policy [Policy Text Block]

'

'

Debt Issue Costs

Direct costs incurred in connection with issuing debt securities or obtaining debt or other credit arrangements are recorded as debt issue costs and are amortized as interest expense over the term of the related debt.

Property, Plant and Equipment, Policy [Policy Text Block]

'

'

Property and Equipment

Property and equipment represent costs associated with leasehold improvements, software, and computer and office equipment. Property and equipment is stated at cost. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets.

Intangible Assets, Finite-Lived, Policy [Policy Text Block]

'

'

Intangible Assets

Intangible Assets

Our intangible assets pertain to capitalized software costs and our website domain address. We capitalize costs related to software developed or obtained for internal use when management commits to funding the project, the project completes the preliminary project stage and the software will be used to perform the function intended. Capitalization of such costs ceases when the project is substantially complete and ready for its intended use.

Our intangible assets pertain to capitalized software costs and our website domain address. We capitalize costs related to software developed or obtained for internal use when management commits to funding the project, the project completes the preliminary project stage and the software will be used to perform the function intended. Capitalization of such costs ceases when the project is substantially complete and ready for its intended use.

We periodically review the carrying values of our long-lived assets when events or changes in circumstances indicate that it is more likely than not that their carrying values may exceed their fair values, and record an impairment charge when considered necessary. When circumstances indicate that an impairment of value may have occurred, we test such assets for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of such assets and their eventual disposition to their carrying amounts. If the undiscounted future cash flows are less that the carrying amount of the asset, an impairment loss, measured as the excess of the carrying amount of the asset over its estimated fair value, is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.

We periodically review the carrying values of our long-lived assets when events or changes in circumstances indicate that it is more likely than not that their carrying values may exceed their fair values, and record an impairment charge when considered necessary. When circumstances indicate that an impairment of value may have occurred, we test such assets for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of such assets and their eventual disposition to their carrying amounts. If the undiscounted future cash flows are less that the carrying amount of the asset, an impairment loss, measured as the excess of the carrying amount of the asset over its estimated fair value, is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.

Convertible Financial Instruments [Policy Text Block]

'

'

Convertible Instruments

Convertible Instruments

We review all of our convertible instruments for the existence of an embedded conversion feature which may require bifurcation, if certain criteria are met. These criteria include circumstances in which:

We review all of our convertible instruments for the existence of an embedded conversion feature which may require bifurcation, if certain criteria are met. These criteria include circumstances in which:

a)

The economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,

a)

The economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,

b)

The hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable GAAP with changes in fair value reported in earnings as they occur, and

b)

The hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable GAAP with changes in fair value reported in earnings as they occur, and

c)

A separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for when the host instrument is deemed to be conventional).

c)

A separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for when the host instrument is deemed to be conventional).

A bifurcated derivative financial instrument may be required to be recorded at fair value and adjusted to market at each reporting period end date. In addition, we may be required to classify certain stock equivalents issued in connection with the underlying debt instrument as derivative liabilities.

For convertible instruments that we have determined should not be bifurcated from their host instruments, we record discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. Also when necessary, we record deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the financing transaction and the effective conversion price embedded in the preferred shares.

A bifurcated derivative financial instrument may be required to be recorded at fair value and adjusted to market at each reporting period end date. In addition, we may be required to classify certain stock equivalents issued in connection with the underlying debt instrument as derivative liabilities.

Finally, if necessary, we will determine the existence of liquidated damage provisions. Liquidated damage provisions are not marked to market, but evaluated based upon the probability that a related liability should be recorded.

For convertible instruments that we have determined should not be bifurcated from their host instruments, we record discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. Also when necessary, we record deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the financing transaction and the effective conversion price embedded in the preferred shares.

Finally, if necessary, we will determine the existence of liquidated damage provisions. Liquidated damage provisions are not marked to market, but evaluated based upon the probability that a related liability should be recorded.

Common Stock Purchase Warrants And Derivative Financial Instruments [Policy Text Block]

'

'

Common Stock Purchase Warrants and Derivative Financial Instruments

Common Stock Purchase Warrants and Derivative Financial Instruments

We review any common stock purchase warrants and other freestanding derivative financial instruments at each balance sheet date and classify them on our balance sheet as:

We review any common stock purchase warrants and other freestanding derivative financial instruments at each balance sheet date and classify them on our balance sheet as:

a)

Equity if they (i) require physical settlement or net-share settlement, or (ii) gives us a choice of net-cash settlement or settlement in our own shares (physical settlement or net-share settlement), or

a)

Equity if they (i) require physical settlement or net-share settlement, or (ii) gives us a choice of net-cash settlement or settlement in our own shares (physical settlement or net-share settlement), or

b)

Assets or liabilities if they (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

b)

Assets or liabilities if they (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

We assess classification of our common stock purchase warrants and other freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.

We assess classification of our common stock purchase warrants and other freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.

Revenue Recognition, Policy [Policy Text Block]

'

'

Revenue Recognition

Revenue Recognition

Revenue is recognized when all of the following conditions exist: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured.

Revenue is recognized when all of the following conditions exist: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured.

Seller Electronics Referrals

Consumer Electronics Referrals

Sellers responding to our advertising campaigns go to our website where they can search for the items they wish to sell using a streamlined point and click interface. Once they have identified their device, they are asked a single question to describe the condition of the device. At this point, they are presented with the “best match,” or uSell’s recommended offer from one of our buyers. We offer this recommendation based on both the price offered by the buyer relative to other buyers and the quality of ratings of the buyer relative to other buyers. The seller may choose to view a larger list of offers from all buyers interested in purchasing their device. During 2013, and into 2014, we earned up front “lead fees” from buyers when sellers accepted offers on our website and filled out a form to request a free shipping kit. This fee was received regardless of whether the sellers ultimately sent in their devices to the buyers. We recognized revenue upon online acceptance of the buyer’s offer by the seller. We record payments received from buyers in advance of offer acceptance as deferred revenue at the time payment is received.

Consumers responding to our advertising campaigns come to our website where they search our database for the item they wish to sell. They are prompted to answer a number of questions regarding the condition of the item and which associated accessories they have, if any. Upon completion of the appraisal questions, they are presented with a listing of offers to purchase their item from our buyers. We earn a fee for providing our buyers with customers and recognize revenue upon acceptance of the buyer’s offer by the Consumer. We receive this fee regardless of whether the Consumer ultimately sends in the device. We record payments received from buyers in advance of offer acceptance as deferred revenue at the time payment is received.

During 2013, our buyers paid fees based on the demand for the individual item which the seller was seeking to sell. Fees were not based on the value of the item sold. For instance, an iPhone might have had a higher fee than an Android, even if that particular Android had a higher offer price to the seller.

Until January 2013, all our buyers paid similar fees per referral. The Company received a higher fee for premium electronics, such as smartphones and iPhones, and a lower fee for non-premium electronics.

Beginning in February 2014, we started a transition of our business model, which was phased in over the subsequent six weeks. Under the new model, buyers pay us a commission only when they pay the seller for a received device and we recognize revenue upon payment to the seller.

Beginning in January 2013, we changed our fee structure with our buyers. Our buyers now pay fees based on the demand for the individual item which the Consumer is seeking to sell. Fees are no longer based on the value of the item sold. All other terms of our agreements with our buyers remained the same.

Fulfillment Revenue

Fulfillment Revenue

In December 2012, we began to offer fulfillment services on behalf of our buyers for the items sold by sellers. We act as the agent in these transactions, passing orders booked by our buyers to our fulfillment vendors, who then assemble the kits and mail them directly to the sellers. We earn a standard fee from our buyers and recognize revenue upon shipment of the kits to the sellers. We evaluated the presentation of revenue on a gross versus net basis and determined that since we perform as an agent without assuming the risks and rewards of ownership of the goods, revenue should be reported on a net basis.

In December 2012, we began to offer fulfillment services on behalf of our buyers for the items sold by Consumers. We act as the agent in these transactions, passing orders booked by our buyers to our vendors, who then assemble the kits and mail them directly to the Consumers. We earn a standard fee from our buyers and recognize revenue upon shipment of the kits to the Consumers. We evaluated the presentation of revenue on a gross versus net basis and determined that since we perform as an agent without assuming the risks and rewards of ownership of the goods, revenue should be reported on a net basis.

Advertising Revenue

Advertising Revenue

Advertising revenues primarily come from payments for text-based sponsored links and display advertisements. Generally, our advertisers pay us on a cost per click, or CPC basis, which means advertisers pay us only when someone clicks on one of their advertisements, or on a cost per thousand impression basis, or CPM. Paying on a CPM basis means that advertisers pay us based on the number of times their advertisements appear on our websites or mobile applications.

Advertising revenues primarily come from payments for text-based sponsored links and display advertisements. Generally, our advertisers pay us on a cost per click, or CPC basis, which means advertisers pay us only when someone clicks on one of their advertisements, or on a cost per thousand impression basis, or CPM. Paying on a CPM basis means that advertisers pay us based on the number of times their advertisements appear on our websites or mobile applications.

Cost Of Revenue [Policy Text Block]

'

'

Cost of Revenue

Cost of Revenue

Our cost of revenue consists primarily of costs to maintain our website, including amortization expense on our technology platform software.

Our cost of revenue consists primarily of costs to maintain our website, including depreciation expense on technology platform software.

Advertising Costs, Policy [Policy Text Block]

'

'

Advertising

Advertising

Advertising costs are expensed as they are incurred and are included in sales and marketing expenses. Advertising expense amounted to $1,060,969 and $837,847 for the three months ended March 31, 2014 and 2013, respectively.

Advertising costs are expensed as they are incurred and are included in sales and marketing expenses. Advertising expense amounted to approximately $4,461,000 and $2,422,000 for the years ended December 31, 2013 and 2012, respectively.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

'

'

Share-Based Payment Arrangements

Share-Based Payment Arrangements

We account for stock options in accordance with Accounting Standards Codification (“ASC”) 718: Compensation - Stock Compensation (“ASC 718”). ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.

We account for stock options in accordance with Accounting Standards Codification (“ASC”) 718, “Compensation - Stock Compensation.” ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.

Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense for the three months ended March 31, 2014 and 2013.

Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense in the accompanying consolidated statements of operations.

Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.

Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.

Income Tax, Policy [Policy Text Block]

'

'

Income Taxes

We account for income taxes in accordance with ASC Topic 740, “Income Taxes,” which requires that we recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized.

ASC Topic 740-20, “Income Taxes – Intraperiod Tax Allocation,” clarifies the accounting for uncertainties in income taxes recognized in accordance with ASC Topic 740-20 by prescribing guidance for the recognition, de-recognition and measurement in financial statements of income tax positions taken in previously filed tax returns or tax positions expected to be taken in tax returns, including a decision whether to file or not to file in a particular jurisdiction. ASC Topic 740-20 requires that any liability created for unrecognized tax benefits is disclosed. The application of ASC Topic 740-20 may also affect the tax bases of assets and liabilities and therefore may change or create deferred tax liabilities or assets. We would recognize interest and penalties related to unrecognized tax benefits in income tax expense

Earnings Per Share, Policy [Policy Text Block]

'

'

Net Loss per Share

Net Loss per Share

Basic loss per share (“EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method (by using the average stock price for the period to determine the number of shares assumed to be purchased from the exercise of stock options or warrants) and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.

Basic loss per share (“EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method, and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.

The computation of basic and diluted loss per share at March 31, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

The computation of basic and diluted loss per share for the years ended December 31, 2013 and 2012 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

Three Months Ended March 31,

Years Ended December 31,

2014

2013

2013

2012

Convertible Series A Preferred Stock

100,000

-

Convertible Notes Payable

373,333

-

Convertible Series B Preferred Stock

60,415

62,002

Convertible Series A Preferred Stock

-

59,302

Convertible Series C Preferred Stock

146,667

-

Convertible Series B Preferred Stock

62,002

131,864

Convertible Series D Preferred Stock

-

83,333

Convertible Series C Preferred Stock

-

-

Convertible Series E Preferred Stock

103,232

-

Unvested restricted stock

248,941

366,667

Unvested Restricted Stock and Restricted Stock Units

238,885

316,667

Stock Warrants

476,270

547,922

Stock Warrants

281,686

546,906

Stock Options

557,413

439,611

Stock Options

542,995

478,546

1,717,959

1,545,366

1,473,880

1,487,454

Legal Matters and Contingencies [Policy Text Block]

'

'

Legal Proceedings

Legal Proceedings

From time to time, we are a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, we are not aware of any proceeding, threatened or pending, against us which, if determined adversely, would have a material effect on our business, results of operations, cash flows or financial position.

From time to time, we are a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, we are not aware of any proceeding, threatened or pending, against us which, if determined adversely, would have a material effect on our business, results of operations, cash flows or financial position.

In August 2011, the Florida Attorney General (the “AG”) initiated an official investigation into whether or not we engaged in unfair trade practices in violation of its “Little FTC Act.” The investigation was due to consumer complaints. Under Florida law, the remedies included actual damages, civil penalties, and attorneys’ fees. We provided a comprehensive response to the AG demonstrating that we acted properly. In April 2012, we met with the AG to discuss the matter and address their concerns. The AG submitted a proposed settlement in which the Company would reimburse the AG $20,000 for the costs of the investigation. In March 2013, we entered into a Settlement Agreement with the AG, pursuant to which we agreed to reimburse the AG $20,000 for investigative costs and My Gold Envelope, Inc., our subsidiary, agreed not to engage in the precious metals business. The Company paid the amount owed to the AG during the year ended December 31, 2013.

Concentration Risk Credit Risk [Policy Text Block]

'

'

Customer Concentrations

Customer and Vendor Concentrations

The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.

The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.

Percentage of

Percentage of Accounts

Revenue During the

Receivable at

Percentage of

Percentage of Accounts

Three Months Ended

Revenue During the

Receivable at

March 31,

March 31,

December 31,

Years Ended

December 31,

2014

2013

2014

2013

December 31,

Buyer A

14

%

22

%

-

3

%

2013

2012

2013

2012

Buyer B

11

%

20

%

18

%

14

%

Buyer A

25

%

1

%

3

%

13

%

Buyer C

10

%

11

%

-

1

%

Buyer B

18

%

17

%

14

%

9

%

Buyer D

5

%

-

30

%

35

%

Buyer C

8

%

18

%

4

%

6

%

Buyer E

3

%

-

24

%

-

Buyer D

1

%

13

%

2

%

10

%

Buyer F

-

-

-

17

%

Buyer E

-

14

%

-

26

%

Buyer F

-

-

35

%

-

Buyer G

-

-

17

%

-

Buyer H

-

4

%

-

13

%

New Accounting Pronouncements, Policy [Policy Text Block]

'

'

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board issued ASU, No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). ASU 2013-11 provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013, with an option for early adoption. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

In July 2013, the FASB ASU, No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). ASU 2013-11 provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013, with an option for early adoption. The Company intends to adopt this guidance at the beginning of our first quarter of fiscal year 2014, and does not expect the adoption of this standard will have a material impact on its financial statements.

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	3 Months Ended										12 Months Ended
	Mar. 31, 2014										Dec. 31, 2013
Accounting Policies [Abstract]	'										'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'										'
	The computation of basic and diluted loss per share at March 31, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:										The computation of basic and diluted loss per share for the years ended December 31, 2013 and 2012 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:
		Three Months Ended March 31,										Years Ended December 31,
		2014		2013								2013		2012
	Convertible Series A Preferred Stock	100,000		-							Convertible Notes Payable	373,333		-
	Convertible Series B Preferred Stock	60,415		62,002							Convertible Series A Preferred Stock	-		59,302
	Convertible Series C Preferred Stock	146,667		-							Convertible Series B Preferred Stock	62,002		131,864
	Convertible Series D Preferred Stock	-		83,333							Convertible Series C Preferred Stock	-		-
	Convertible Series E Preferred Stock	103,232		-							Unvested restricted stock	248,941		366,667
	Unvested Restricted Stock and Restricted Stock Units	238,885		316,667							Stock Warrants	476,270		547,922
	Stock Warrants	281,686		546,906							Stock Options	557,413		439,611
	Stock Options	542,995		478,546								1,717,959		1,545,366
		1,473,880		1,487,454
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	'										'
	The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.										The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.
		Percentage of					Percentage of Accounts
		Revenue During the					Receivable at					Percentage of					Percentage of Accounts
		Three Months Ended										Revenue During the					Receivable at
		March 31,					March 31,		December 31,			Years Ended					December 31,
		2014			2013		2014		2013			December 31,
	Buyer A	14	%		22	%	-		3	%		2013			2012		2013		2012
	Buyer B	11	%		20	%	18	%	14	%	Buyer A	25	%		1	%	3	%	13	%
	Buyer C	10	%		11	%	-		1	%	Buyer B	18	%		17	%	14	%	9	%
	Buyer D	5	%		-		30	%	35	%	Buyer C	8	%		18	%	4	%	6	%
	Buyer E	3	%		-		24	%	-		Buyer D	1	%		13	%	2	%	10	%
	Buyer F	-			-		-		17	%	Buyer E	-			14	%	-		26	%
											Buyer F	-			-		35	%	-
											Buyer G	-			-		17	%	-
											Buyer H	-			4	%	-		13	%

Fair_Value_Tables

Fair Value (Tables)	3 Months Ended									12 Months Ended
	Mar. 31, 2014									Dec. 31, 2013
Fair Value Disclosures [Abstract]	'									'
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Table Text Block]	'									'
	The following are the major categories of assets and liabilities measured at fair value on a recurring basis at March 31, 2014 and December 31, 2013, using quoted prices in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):									The following are the major categories of liabilities measured at fair value on a recurring basis at December 31, 2013 and 2012, using quoted prices in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
		At March 31, 2014				At December 31, 2013					At December 31,
		Assets		Liabilities		Assets		Liabilities			2013				2012
	Level 1											Assets		Liabilities		Assets		Liabilities
	None	$	-	$	-	$	-	$	-	Level 1
	Level 2									None	$	-	$	-	$	-	$	-
	None		-		-		-		-	Level 2
	Level 3									None	$	-	$	-	$	-	$	-
	Derivative liability		-		-		-		1,001,385	Level 3
		$	-	$	-	$	-	$	1,001,385	Derivative liability	$	-	$	1,001,385	$	-	$	153,776
Fair Value, by Balance Sheet Grouping [Table Text Block]	'									'
	The following table reflects the change in fair value of our derivative liabilities for the three months ended March 31, 2014:									The following table reflects the change in fair value of our derivative liabilities for the years ended December 31, 2013 and 2012:
	Balance at beginning of period	$	1,001,385								Years Ended December 31,
	Change in value of derivative liability - convertible notes		681,122								2013				2012
	Reclassification of price protection feature to additional paid in capital - convertible notes		-1,682,507									Assets		Liabilities		Assets		Liabilities
	Balance at end of period	$	-
										Balance at beginning of period	$	-	$	153,776	$	-	$	29,837
										Change in value of derivative liability - Series A preferred stock		-		-47,876		-		2,089,744
										Reclassification of beneficial conversion feature to additional paid in capital - Series A preferred stock		-		-105,900		-		-
										Derivative liability arising from Series A preferred stock		-		-		-		191,630
										Elimination of beneficial conversion feature - Series A preferred stock		-		-		-		-2,127,598
										Derivative liability arising from issuance of convertible notes payable		-		1,244,351		-		-
										Change in value of derivative liability - convertible notes		-		-149,398		-		-28,244
										Reclassification of beneficial conversion feature to additional paid in capital - convertible notes				-93,568		-		-
										Elimination of beneficial conversion feature - convertible notes		-		-		-		-1,593
										Balance at end of period	$	-	$	1,001,385	$	-	$	153,776

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
	Property and equipment consists of the following at December 31, 2012 and 2011:
						Estimated
		2013		2012		Useful Life
	Hardware and Software	$	14,721	$	18,927	3 years
	Furniture and Fixtures		5,645		-	3 years
	Leasehold Improvements		-		4,457	*
	Office Equipment		-		3,386	3 years
			20,366		26,770
	Less: Accumulated Depreciation		-13,077		-20,264
	Property and Equipment, Net	$	7,289	$	6,506
	* The shorter of three years or the life of the lease.

Intangible_Assets_Tables

Intangible Assets (Tables)	3 Months Ended							12 Months Ended
	Mar. 31, 2014							Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'							'
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'							'
	Intangible assets consist of the following:							Intangible assets consist of the following:
		Capitalized		Website		Total			Capitalized		Website
		Software		Domain					Software		Domain			Total
	Gross value at March 31, 2014	$	1,460,994	$	67,752	$	1,528,746	Gross value at December 31, 2013	$	1,317,976	$	67,752	$	1,385,728
	Accumulated amortization at March 31, 2014		-632,521		-67,752		-700,273	Accumulated amortization at December 31, 2013		-511,012		-67,752		-578,764
	Net value at March 31, 2014	$	828,473	$	-	$	828,473	Net value at December 31, 2013	$	806,964	$	-	$	806,964
	Gross value at December 31, 2013	$	1,317,976	$	67,752	$	1,385,728	Gross value at December 31, 2012	$	777,034	$	67,752	$	844,786
	Accumulated amortization at December 31, 2013		-511,012		-67,752		-578,764	Accumulated amortization at December 31, 2012		-155,103		-65,530		-220,633
	Net value at December 31, 2013	$	806,964	$	-	$	806,964	Net value at December 31, 2012	$	621,931	$	2,222	$	624,153
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	'							'
	Future annual estimated amortization expense is summarized as follows:							Future annual estimated amortization expense is summarized as follows:
	Years ending December 31,							Years ending December 31,
	2014 (remaining nine months)	$	396,278					2014	$	452,223
	2015		335,705					2015		301,681
	2016		90,119					2016		53,060
	2017		6,371						$	806,964
		$	828,473

Convertible_Note_Tables

Convertible Note (Tables)	3 Months Ended			12 Months Ended
	Mar. 31, 2014			Dec. 31, 2013
Debt Disclosure [Abstract]	'			'
Schedule Of Estimated Fair Value Of Convertible Notes Conversion Features [Table Text Block]	'			'
				On January 27, 2012, we determined that the fair value of the derivative liability pertaining to the 2011 Convertible Notes was $1,593 based on the following weighted average variables:
				Expected dividends	0	%
				Expected volatility	189.81	%
				Expected term	5 months
				Risk free interest rate	0.07	%
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	'			'
	On the date of conversion, we determined the fair value of the derivative liability to be $1,682,507 using the Black-Scholes option pricing model with the following assumptions:			At the time of the issuances, we determined that the price protection feature on the 2013 Convertible Notes constituted a derivative liability and estimated the fair value of such liability to be $1,244,351 using the Black-Scholes option pricing model using the following weighted average assumptions:
	Risk-free interest rate	0.22	%	Risk-free interest rate	0.28 – 0.40	%
	Expected dividend yield	0	%	Expected dividend yield	0	%
	Expected volatility	239.41	%	Expected volatility	261.45 – 278.90	%
	Expected term	1.35 – 1.77 years		Expected life	2 years
				On the date of conversion, we determined that the fair value of the derivative liability was $93,568 using the Black-Scholes option pricing model using the following weighted average assumptions:
				Risk-free interest rate	0.32	%
				Expected dividend yield	0	%
				Expected volatility	268.86	%
				Expected life	1.85 – 1.93 years
				On December 31, 2013, we determined that the fair value of the derivative liability pertaining to the remaining 2013 Convertible Notes was $1,001,385 using the Black-Scholes option pricing model using the following weighted average assumptions:
				Risk-free interest rate	0.38	%
				Expected dividend yield	0	%
				Expected volatility	255.94	%
				Expected life	1.5 – 1.9 years
Convertible Debt [Table Text Block]	'			'
				The components of 2013 Convertible Notes at December 31, 2013 are as follows:
							Interest			Conversion
					Balance		Rate		Maturity	Price
				Balance - December 31, 2012	$	-
				Borrowings		1,220,000	5	%	July 5, 2015 through December 3, 2015	$	0.2
				Conversions		-100,000
				Unamortized debt discount		-873,872
				Balance - December 31, 2013	$	246,128

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'
	Future minimum commitments are as follows:
	For the Year Ended December 31,
	2014	$	77,625
	2015		51,750
		$	129,375

Stockholders_Equity_Deficit_Ta

Stockholders' Equity (Deficit) (Tables)	3 Months Ended												12 Months Ended
	Mar. 31, 2014												Dec. 31, 2013
Warrants and Rights Fair Value Assumptions [Table Text Block]	'												'
													The estimated fair value of these stock warrants on their date of grant was $43,042, which we estimated using the Black-Scholes option pricing model using the following assumptions:
													Expected dividends	0	%
													Expected volatility	189.81	%
													Expected term	5 years
													Risk free interest rate	0.75	%
													The estimated fair value of these stock warrants on their date of grant was $25,000, which we estimated using the Black-Scholes option pricing model using the following assumptions:
													Expected dividends	0	%
													Expected volatility	195.66	%
													Expected term	5 years
													Risk free interest rate	1.06	%
Class Of Warrant Or Right Activity [Table Text Block]	'												'
	The following summarizes our warrant activity for the three months ended March 31, 2014:												The following summarizes our warrant activity for the years ended December 31, 2013 and 2012:
		Number of			Weighted			Weighted			Aggregate			Series A Preferred Stock					Common Stock
		Warrants			Average			Average			Intrinsic Value							Weighted					Weighted
					Exercise Price			Remaining								Weighted		Average				Weighted	Average
								Contractual Life								Average		Remaining				Average	Remaining
								(in Years)						Number of		Exercise		Contractual Life	Number of			Exercise	Contractual Life
	Outstanding - December 31, 2013		476,270			3.02			3.1		$	-		Warrants		Price		(in Years)	Warrants			Price	(in Years)
	Granted		22,083			3							Outstanding - December 31, 2011	-		$	-	-		18,799	$	194.4	1.1
	Exercised		-			-							Granted	25,000			0.2			541,667		3
	Cancelled/Forfeited		-216,667			3							Exercised	-			-			-		-
	Outstanding - March 31, 2014		281,686		$	3.04			3		$	555,224	Cancelled/Forfeited	-25,000			0.2			-12,543		243.65
													Outstanding - December 31, 2012	-		$	-	-		547,922		4.05	4
	Exercisable - March 31, 2014		281,686		$	3.04			3		$	555,224	Granted	-			-			-		-
													Exercised	-			-			-66,667		3
													Cancelled/Forfeited	-			-			-4,986		117.84
													Outstanding - December 31, 2013	-		$	-	-		476,270	$	3.02	3.1
													Exercisable - December 31, 2013	-		$	-	-		476,270	$	3.02	3.1
Share Based Compensation Arrangement By Share Based Payment Award Options Fair Value Assumptions [Table Text Block]	'												'
	These options had a fair value of $90,431 using the Black-Scholes option pricing model with the following assumptions:												These options had an aggregate fair value of $48,935 using the Black-Scholes option-pricing model using the following weighted average assumptions:
	Risk-free interest rate	1.19 – 1.35	%										Risk free interest rate	0.67% - 1.67	%
	Expected dividend yield	0	%										Expected dividends	0	%
	Expected volatility	57.22 – 56.95	%										Expected volatility	194.68% - 207.45	%
	Expected term	3.75 years											Expected term	5 – 10 years
													These options had a fair value of $65,441 using the Black-Scholes option-pricing model using the following weighted average assumptions:
													Risk free interest rate	0.83% - 1.91	%
													Expected dividends	0	%
													Expected volatility	196.04% - 204.98	%
													Expected term	5 – 10 years
													These options had a fair value of $3,150 using the Black-Scholes option-pricing model using the following assumptions:
													Risk free interest rate	1.9	%
													Expected dividends	0	%
													Expected volatility	189.81	%
													Expected term	10 years
													These options had an aggregate fair value of $1,289,250 using the Black-Scholes option-pricing model using the following weighted average assumptions:
													Risk free interest rate	0.60% - 0.69	%
													Expected dividends	0	%
													Expected volatility	204.30% - 205.26	%
													Expected term	5 years
													These options had a fair value of $384,387 using the Black-Scholes option-pricing model with the following assumptions:
													Risk free interest rate	0.54% - 1.37	%
													Expected dividends	0	%
													Expected volatility	204.36% - 219.25	%
													Expected term	5 years
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'												'
	The following table summarizes our stock option activity for the three months ended March 31, 2014:												The following table summarizes our stock option activity for the year ended December 31, 2013:
		Number of		Weighted			Weighted		Aggregate									Weighted
		Options		Average			Average		Intrinsic Value									Average
				Exercise Price			Remaining										Weighted	Remaining
							Contractual										Average	Contractual
							Life							Number of			Exercise	Life		Aggregate
							(in Years)							Options			Price	(in Years)		Intrinsic Value
	Outstanding - December 31, 2013	557,413		$	4.98		4		$	5,250			Outstanding - December 31, 2012	439,611		$	6.15	4.8	$	-
	Granted	59,332			3.92								Granted	144,333			3.04
	Exercised	-			-								Exercised	-			-
	Forfeited or Canceled	-73,750			3.01								Forfeited or Canceled	-26,531			13.16
	Outstanding - March 31, 2014	542,995		$	5.14		3.9		$	869,661			Outstanding - December 31, 2013	557,414		$	4.98	4	$	5,250
	Exercisable - March 31, 2014	275,296		$	6.81		3.9		$	404,577			Exercisable - December 31, 2013	320,373		$	6.18	4	$	-
Schedule of Nonvested Share Activity [Table Text Block]	'												'
	The following table summarizes our stock option activity for non-vested options for the three months ended March 31, 2014:												The following table summarizes our stock option activity for non-vested options for the year ended December 31, 2013:
		Number of			Weighted
		Options			Average											Weighted
					Grant Date											Average
					Fair Value									Number of		Grant Date
	Balance at December 31, 2013		237,040		$	4.45								Options		Fair Value
	Granted		59,332			1.52							Balance at December 31, 2012	263,765		$	8.4
	Vested		-21,590			-6.91							Granted	144,333		$	2.66
	Forfeited or Canceled		-7,083			-3.01							Vested	-146,243		$	-10.25
	Balance at March 31, 2014		267,699		$	3.66							Forfeited or Canceled	-24,815		$	-13.16
													Balance at December 31, 2013	237,040		$	4.45
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	'												'
	A summary of the restricted stock award activity for the three months ended March 31, 2014 is as follows:												A summary of the restricted stock award activity for the year ended December 31, 2013 is as follows:
		Number of												Number of
		Shares												Shares
	Unvested Outstanding at December 31, 2013		248,941										Unvested Outstanding at December 31, 2012	366,667
	Granted		32,000										Granted (1)	502,663
	Vested		-42,056										Cancelled	-216,667
	Unvested Outstanding at March 31, 2014		238,885										Vested	-403,722
													Unvested Outstanding at December 31, 2013	248,941
													(1) Includes 183,331 RSUS granted, but not considered issued or outstanding until vested.
Convertible Series A Preferred Stock [Member] | January 2012 [Member]	'												'
Estimated Fair Value Of Derivative Liability Based On Weighted Average Assumptions [Table Text Block]	'												'
													At that time, we determined that the price protection feature on the 7,006,000 shares of 2011 Series A PS constituted a derivative liability and estimated the fair value of such liability to be $191,630 using the Black-Scholes option pricing model using the following weighted average assumptions:
													Expected dividends	0	%
													Expected volatility	190.40% - 191.75	%
													Expected term	5 years
													Risk free interest rate	0.71% - 0.88	%
Convertible Series A Preferred Stock [Member] | December 2012 [Member]	'												'
Estimated Fair Value Of Derivative Liability Based On Weighted Average Assumptions [Table Text Block]	'												'
													On December 31, 2012, we determined that the fair value of the derivative liability pertaining to the 177,906 outstanding shares of 2011 Series A PS was $153,776 using the Black-Scholes option pricing model based on the following weighted average variables:
													Expected dividends	0	%
													Expected volatility	209.62	%
													Expected term	4 years
													Risk free interest rate	0.72	%
Convertible Series A Preferred Stock [Member] | March 2013 [Member]	'												'
Estimated Fair Value Of Derivative Liability Based On Weighted Average Assumptions [Table Text Block]	'												'
													We determined that the fair value of the derivative liability pertaining to the 177,906 shares of 2011 Series A PS immediately prior to the conversion was $105,900 using the Black-Scholes option pricing model based on the following weighted average variables:
													Expected dividends	0	%
													Expected volatility	214.26	%
													Expected term	4 years
													Risk free interest rate	0.81	%

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	'
	The domestic and foreign components of our consolidated net pre-tax loss from operations for the respective periods are as follows:
		Year ended December 31,
		2013		2012
	Domestic loss	$	-4,442,000	$	-8,849,000
	Foreign income (loss)		179,000		—
	Consolidated net loss before income tax expense	$	-4,263,000	$	-8,849,000
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
	Significant deferred tax assets are as follows:
		December 31,
		2013		2012
	Current deferred tax assets:
	Accrued Expenses	$	30,000	$	119,000
	Allowance for Doubtful Accounts		1,000		38,000
	Subtotal current deferred tax asset		31,000		157,000
	Non-current deferred tax assets and liabilities:
	Intangible Assets	$	27,000	$	29,000
	Fixed Assets		-123,000		-112,000
	Discount on Convertible Notes		-329,000		—
	Derivative Liability		377,000		—
	Stock Options		2,477,000		1,972,000
	Net operating loss carryover		8,652,000		7,322,000
	Subtotal non-current deferred tax asset		11,081,000		9,211,000
	Total deferred tax asset	$	11,112,000	$	9,368,000
	Less:  valuation allowance		-11,112,000		-9,368,000
	Net deferred tax assets	$	—	$	—
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
	The actual tax expense (benefit) differs from the expected tax expense (benefit) for the years ended December 31, 2013 and 2012 (computed by applying the U.S. Federal Corporate income tax rate of 34% to income before taxes and 5.5% for State income taxes, a blended rate of 37.63%) as follows:
		December 31,
		2013		2012
	Expected tax expense (benefit) - federal	$	-1,449,000	$	-3,009,000
	Expected tax expense (benefit) - state		-159,000		-321,000
	Foreign rate differential		-23,000		—
	Change in fair value of derivative liability - embedded conversion feature		—		776,000
	Permanent items		22,000		1,000
	True-up		-135,000		—
	Change in valuation allowance		1,744,000		2,553,000
	Actual tax expense	$	—	$	—

Organization_and_Business_Deta

Organization and Business (Details Textual)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Jan. 21, 2014	Dec. 31, 2012
Organization and Business [Line Items]	'	'	'	'
Stockholders Equity, Reverse Stock Split	'On January 21, 2014, we effected a 1-for-15 reverse stock split of our common stock (Reverse Split). As a result of the Reverse Split, every fifteen shares of our common stock were combined into one share of common stock. Immediately after the January 21, 2014 effective date, we had 4,907,462 shares of common stock outstanding.	'On January 21, 2014, we effected a 1-for-15 reverse stock split of our common stock (Reverse Split). As a result of the Reverse Split, every fifteen shares of our common stock was combined into one share of common stock. Immediately after the January 21, 2014 effective date, we had 4,907,462 shares of common stock outstanding.	'	'
Common Stock, Shares, Outstanding	5,822,983	4,907,462	4,907,462	3,143,082

Going_Concern_Details_Textual

Going Concern (Details Textual) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Apr. 15, 2014
					Subsequent Event [Member]
Going Concern [Line Items]	'	'	'	'	'
Net Loss	($2,846,372)	($1,562,651)	($4,262,856)	($8,849,371)	'
Net Cash Used In Operating Activities	749,000	'	1,778,000	'	'
Accumulated deficit	-47,600,505	'	-44,754,133	-40,491,277	'
Working Capital	770,000	'	1,269,000	'	'
Stock Registered for Future Issuance, Value	'	'	'	'	$10,000,000

Significant_Accounting_Policie3

Significant Accounting Policies (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,473,880	1,487,454	1,717,959	1,545,366
Convertible Notes Payable [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	'	'	373,333	0
Series A Convertible Preferred Stock [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	100,000	0	0	59,302
Series B Convertible Preferred Stock [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	60,415	62,002	62,002	131,864
Series C Convertible Preferred Stock [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	146,667	0	0	0
Series D Convertible Preferred Stock [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	83,333	'	'
Series E Convertible Preferred Stock [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	103,232	0	'	'
Unvested Restricted Stock and Restricted Stock Units [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	238,885	316,667	248,941	366,667
Stock Warrants [member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	281,686	546,906	476,270	547,922
Stock Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	542,995	478,546	557,413	439,611

Significant_Accounting_Policie4

Significant Accounting Policies (Details 1)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Buyer A [Member] | Sales Revenue, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	14.00%	22.00%	25.00%	1.00%
Buyer A [Member] | Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	0.00%	3.00%	3.00%	13.00%
Buyer B [Member] | Sales Revenue, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	11.00%	20.00%	18.00%	17.00%
Buyer B [Member] | Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	18.00%	14.00%	14.00%	9.00%
Buyer C [Member] | Sales Revenue, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	10.00%	11.00%	8.00%	18.00%
Buyer C [Member] | Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	0.00%	1.00%	4.00%	6.00%
Buyer D [Member] | Sales Revenue, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	5.00%	0.00%	1.00%	13.00%
Buyer D [Member] | Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	30.00%	35.00%	2.00%	10.00%
Buyer E [Member] | Sales Revenue, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	3.00%	0.00%	0.00%	14.00%
Buyer E [Member] | Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	24.00%	0.00%	0.00%	26.00%
Buyer F [Member] | Sales Revenue, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	0.00%	0.00%	0.00%	0.00%
Buyer F [Member] | Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	0.00%	17.00%	35.00%	0.00%
Buyer G [Member] | Sales Revenue, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	'	'	0.00%	0.00%
Buyer G [Member] | Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	'	'	17.00%	0.00%
Buyer H [Member] | Sales Revenue, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	'	'	0.00%	4.00%
Buyer H [Member] | Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration Risk, Percentage	'	'	0.00%	13.00%

Significant_Accounting_Policie5

Significant Accounting Policies (Details Textual) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Significant Accounting Policies [Line Items]	'	'	'	'
Cash, Uninsured Amount	'	'	$187,000	$1,400,000
Allowance for Doubtful Accounts Receivable	12,335	'	3,500	100,299
Advertising Expense	1,060,969	837,847	4,461,000	2,422,000
Loss Contingency Accrual, Beginning Balance	'	20,000	'	'
Loss Contingency Accrual, Payments	'	'	$20,000	'

Fair_Value_Details

Fair Value (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]	'	'	'
Derivative Asset, Fair Value, Net	$0	$0	'
Derivative Liability, Fair Value, Net	0	1,001,385	'
Fair Value, Inputs, Level 1 [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]	'	'	'
Derivative Asset, Fair Value, Net	0	0	0
Derivative Liability, Fair Value, Net	0	0	0
Fair Value, Inputs, Level 2 [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]	'	'	'
Derivative Asset, Fair Value, Net	0	0	0
Derivative Liability, Fair Value, Net	0	0	0
Fair Value, Inputs, Level 3 [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]	'	'	'
Derivative Asset, Fair Value, Net	0	0	0
Derivative Liability, Fair Value, Net	$0	$1,001,385	$153,776

Fair_Value_Details_1

Fair Value (Details 1) (USD $)

3 Months Ended

12 Months Ended

12 Months Ended

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Derivative Financial Instruments, Liabilities [Member]

Derivative Financial Instruments, Liabilities [Member]

Derivative Financial Instruments, Liabilities [Member]

Derivative Financial Instruments, Liabilities [Member]

Derivative Financial Instruments, Liabilities [Member]

Derivative Financial Instruments, Liabilities [Member]

Derivative Financial Instruments, Liabilities [Member]

Derivative Financial Instruments, Assets [Member]

Derivative Financial Instruments, Assets [Member]

Derivative Financial Instruments, Assets [Member]

Derivative Financial Instruments, Assets [Member]

Derivative Financial Instruments, Assets [Member]

Derivative Financial Instruments, Assets [Member]

Derivative Financial Instruments, Assets [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance at beginning of period

$1,001,385

$1,001,385

$153,776

$29,837

'

'

'

'

$0

$0

$0

'

'

'

'

Change in value of derivative liability - Series A preferred stock

'

'

'

'

'

'

-47,876

2,089,744

'

'

'

'

'

0

0

Reclassification of beneficial conversion feature to additional paid in capital - Series A preferred stock

'

'

'

'

'

'

-105,900

0

'

'

'

'

'

0

0

Derivative liability arising from Series A preferred stock

'

'

'

'

'

'

0

191,630

'

'

'

'

'

0

0

Elimination of beneficial conversion feature - Series A preferred stock

'

'

'

'

'

'

0

-2,127,598

'

'

'

'

'

0

0

Derivative liability arising from issuance of convertible notes payable

'

'

'

'

1,244,351

0

'

'

'

'

'

0

0

'

'

Change in value of derivative liability - convertible notes

681,122

'

'

'

-149,398

-28,244

'

'

'

'

'

0

0

'

'

Reclassification of price protection feature to additional paid in capital - convertible notes

-1,682,507

'

'

'

-93,568

0

'

'

'

'

'

'

0

'

'

Elimination of beneficial conversion feature - convertible notes

'

'

'

'

0

-1,593

'

'

'

'

'

0

0

'

'

Balance at end of period

$0

$1,001,385

$153,776

$29,837

'

'

'

'

$0

$0

$0

'

'

'

'

Other_Receivables_Details_Text

Other Receivables (Details Textual) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Feb. 27, 2013
Other Receivables [Line Items]	'	'	'
Financing Receivable, Gross	'	$15,000	'
Other Receivables	'	15,000	'
Promissory Note One [Member]	'	'	'
Other Receivables [Line Items]	'	'	'
Financing Receivable, Gross	'	'	65,771
Debt Instrument Periodic Receipt Principal	1,028	1,028	'
Debt Instrument, Interest Rate, Stated Percentage	'	'	5.00%
Debt Instrument, Maturity Date	4-Jun-14	4-Jun-14	'
Other Receivables	'	15,000	'
Promissory Note Two [Member]	'	'	'
Other Receivables [Line Items]	'	'	'
Debt Instrument Periodic Receipt Principal	500	500	'
Other Receivables	$8,835	$14,257	'

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Hardware and Software [Member]

Hardware and Software [Member]

Furniture and Fixtures [Member]

Furniture and Fixtures [Member]

Leasehold Improvements [Member]

Leasehold Improvements [Member]

Office Equipment [Member]

Office Equipment [Member]

Property and Equipment:

'

'

'

'

'

'

'

'

'

'

'

Property and Equipment, Gross

'

$20,366

$26,770

$14,721

$18,927

$5,645

$0

$0

$4,457

$0

$3,386

Less: Accumulated Depreciation

'

-13,077

-20,264

'

'

'

'

'

'

'

'

Property and Equipment, Net

$6,244

$7,289

$6,506

'

'

'

'

'

'

'

'

Property and Equipment, Estimated Useful Life

'

'

'

'3 years

'

'3 years

'

'

[1]

'

'3 years

'

[1]

The shorter of three years or the life of the lease.

Property_and_Equipment_Details1

Property and Equipment (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Depreciation	$4,862	$6,984

Acquisition_Details_Textual

Acquisition (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2012
Business Acquisition [Line Items]	'
Business Combination, Consideration Transferred, Total	$500,000
Noncontrolling Interest, Ownership Percentage by Parent	100.00%
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	350,000
Payments to Acquire Businesses, Gross	500,000
Business Acquisition, Transaction Costs	30,924
Comparison technology platform software	500,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	$500,000
Chief Executive Officer [Member]	'
Business Acquisition [Line Items]	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	90,000
Chief Financial Officer [Member]	'
Business Acquisition [Line Items]	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	90,000
Chief Operating Officer [Member]	'
Business Acquisition [Line Items]	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	90,000
Board of Directors Chairman [Member]	'
Business Acquisition [Line Items]	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	25,000
Usell Shareholder [Member]	'
Business Acquisition [Line Items]	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	25,000

Intangible_Assets_Details

Intangible Assets (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]	'	'	'
Gross value	$1,528,746	$1,385,728	$844,786
Accumulated amortization	-700,273	-578,764	-220,633
Net value	828,473	806,964	624,153
Capitalized Software [Member]	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'
Gross value	1,460,994	1,317,976	777,034
Accumulated amortization	-632,521	-511,012	-155,103
Net value	828,473	806,964	621,931
Website Domain [Member]	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'
Gross value	67,752	67,752	67,752
Accumulated amortization	-67,752	-67,752	-65,530
Net value	$0	$0	$2,222

Intangible_Assets_Details_1

Intangible Assets (Details 1) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Years ending December 31,	'	'	'
2014 (remaining nine months)	$396,278	'	'
2014	'	452,223	'
2015	335,705	301,681	'
2016	90,119	53,060	'
2017	6,371	'	'
Net value	$828,473	$806,964	$624,153

Intangible_Assets_Details_Text

Intangible Assets (Details Textual) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Finite-Lived Intangible Assets, Amortization Method	'straight-line basis	'	'straight-line basis	'
Amortization of Intangible Assets	$121,509	$67,785	$358,131	$158,034
Minimum [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Finite-Lived Intangible Asset, Useful Life	'2 years	'	'2 years	'
Maximum [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Finite-Lived Intangible Asset, Useful Life	'3 years	'	'3 years	'

Convertible_Notes_Details

Convertible Notes (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Price Protection Feature [Member]	'	'	'
Expected dividend yield	'	0.00%	'
Expected term	'	'2 years	'
Convertible Notes Payable [Member]	'	'	'
Risk-free interest rate	0.22%	0.32%	0.07%
Expected dividend yield	0.00%	0.00%	0.00%
Expected volatility	239.41%	268.86%	189.81%
Expected term	'	'2 years	'5 months
Convertible Notes Payable One [Member]	'	'	'
Risk-free interest rate	'	0.38%	'
Expected dividend yield	'	0.00%	'
Expected volatility	'	255.94%	'
Maximum [Member] | Price Protection Feature [Member]	'	'	'
Risk-free interest rate	'	0.40%	'
Expected volatility	'	278.90%	'
Maximum [Member] | Convertible Notes Payable [Member]	'	'	'
Expected term	'1 year 9 months 7 days	'1 year 11 months 5 days	'
Maximum [Member] | Convertible Notes Payable One [Member]	'	'	'
Expected term	'	'1 year 10 months 24 days	'
Minimum [Member] | Price Protection Feature [Member]	'	'	'
Risk-free interest rate	'	0.28%	'
Expected volatility	'	261.45%	'
Minimum [Member] | Convertible Notes Payable [Member]	'	'	'
Expected term	'1 year 4 months 6 days	'1 year 10 months 6 days	'
Minimum [Member] | Convertible Notes Payable One [Member]	'	'	'
Expected term	'	'1 year 6 months	'

Convertible_Notes_Details_1

Convertible Notes (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2014	Aug. 16, 2010
Debt Instrument [Line Items]	'	'	'	'
Balance - December 31, 2012	$0	'	$0	'
Conversions	0	-800,000	'	'
Balance - December 31, 2013	246,128	0	0	'
Debt Instrument, Convertible, Conversion Price	'	'	'	$0.30
Convertible Notes Payable [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Balance - December 31, 2012	0	'	'	'
Borrowings	1,220,000	'	'	'
Conversions	-100,000	'	'	'
Unamortized debt discount	-873,872	'	'	'
Balance - December 31, 2013	$246,128	'	'	'
Borrowings, Interest Rate	5.00%	'	'	'
Borrowings, Maturity	'July 5, 2015 through December 3, 2015	'	'	'
Debt Instrument, Convertible, Conversion Price	$0.20	'	'	'

Convertible_Notes_Details_Text

Convertible Notes (Details Textual) (USD $)

3 Months Ended

12 Months Ended

1 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

12 Months Ended

3 Months Ended

1 Months Ended

12 Months Ended

3 Months Ended

1 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jan. 27, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Feb. 28, 2014

Dec. 31, 2013

Mar. 31, 2014

Feb. 28, 2014

Common Stock [Member]

Common Stock [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable One [Member]

Convertible Notes Payable One [Member]

Convertible Notes Payable One [Member]

Convertible Notes Payable One [Member]

Convertible Notes Payable Two [Member]

Convertible Notes Payable Two [Member]

Convertible Notes Payable Two [Member]

Series E Preferred Stock [Member]

Maximum [Member]

Minimum [Member]

Common Stock [Member]

Subsequent Event [Member]

Series E Preferred Stock [Member]

Subsequent Event [Member]

Proceeds from Notes Payable

'

'

'

'

'

'

'

'

$1,220,000

'

$800,000

'

'

'

'

'

'

'

'

'

'

Convertible Notes Payable Per Share

'

'

'

'

'

'

'

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

Accounts Payable, Interest-bearing, Interest Rate

'

'

'

'

'

'

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued

5,878,535

'

4,973,073

3,509,749

'

'

'

'

1,000,000

'

'

'

1,000,000

'

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share

$0.00

'

$0.00

$0.00

$0.00

$0.00

'

'

'

'

'

'

$3.75

$3

'

'

'

'

'

'

'

Common Stock Closing Price

'

'

'

'

'

'

'

'

$4.50

'

'

'

$4.50

'

'

'

'

'

'

'

'

Derivative Liability, Fair Value, Gross Liability

'

'

1,244,351

153,776

'

'

1,593

1,682,507

93,568

'

'

'

'

'

'

'

'

'

'

'

'

Discount On Notes Payable

'

'

'

'

'

'

'

'

1,182,856

'

'

'

'

'

'

'

'

'

'

'

'

Financial Services Costs, Total

'

'

'

'

'

'

'

'

61,495

'

'

'

'

'

'

'

'

'

'

'

'

Derivative, Gain (Loss) on Derivative, Net, Total

-681,122

0

149,398

28,244

'

'

'

681,122

'

28,244

'

'

'

'

4,620

'

'

'

144,778

'

'

Non Cash Interest Expense

'

'

'

'

'

'

'

1,182,856

1,182,856

'

'

'

'

'

'

'

'

'

'

'

'

Accretion of Discount

'

'

'

'

'

'

'

873,872

308,984

'

'

'

'

'

'

'

'

'

'

'

'

Interest Expense, Total

891,279

19

334,678

399,651

'

'

'

8,745

22,788

'

'

'

'

'

'

389,583

'

'

'

'

'

Notes Payable Fee

'

'

'

'

'

'

'

10,970

10,970

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Exercise Price Per Share

'

'

'

'

'

'

'

'

'

$3

$3

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

1,600,000

'

'

'

'

103,232

'

'

'

'

280,427

383,659

'

103,232

103,232

Warrants Sold In Private Placements

'

'

'

'

'

'

'

'

'

533,333

'

'

'

'

'

'

'

'

'

'

'

Additional Paid in Capital, Total

49,229,887

'

44,087,232

41,660,361

'

'

'

'

93,568

1,593

'

'

'

'

'

'

'

'

'

'

'

Short-term Debt, Terms

'

'

'

'

'

'

'

'

'

'

'The 2011 Convertible Notes had a one-year term, an annual interest rate of approximately 0.5%, and, following a qualified financing transaction involving common stock or common stock equivalents in which we received gross proceeds in excess of $500,000 (“Future Financing”), became convertible into our common stock at 50% of the lower of (a) the price per share of common stock, or (ii) the exercise or conversion price of any common stock equivalents used in the financing transaction.

'

'

'

'

'

'

'

'

'

'

Short-term Debt, Percentage Bearing Fixed Interest Rate

'

'

'

'

'

'

'

'

'

'

0.50%

'

'

'

'

'

'

'

'

'

'

Future Financing Value

'

'

'

'

'

'

'

'

'

'

500,000

'

'

'

'

'

'

'

'

'

'

Conversion Rate Percentage

'

'

'

'

'

'

'

'

'

'

50.00%

'

'

'

'

'

'

'

'

'

'

Warrants Exercisable Term

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

Convertible Debt, Fair Value Disclosures

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,001,385

'

'

'

'

'

'

Stock Issued During Period Conversion Of Convertible Notes To Common Stock Share

'

'

'

'

33,514

'

'

'

33,514

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Original Debt, Amount

'

'

0

800,000

'

'

'

'

100,000

'

'

'

'

'

'

'

820,000

820,000

'

300,000

300,000

Debt Conversion, Original Debt, Accrued Interest Amount

'

'

'

'

'

'

'

'

541

'

'

'

'

'

'

'

'

'

'

'

'

Accretion Expense

'

'

'

'

'

'

'

8,645

2,325

'

'

'

'

'

'

'

'

'

'

'

'

Interest Payable

'

'

'

'

'

'

'

'

'

'

'

$9,698

'

'

'

'

$21,294

'

'

$9,698

'

Preferred_Stock_Details_textua

Preferred Stock (Details textual) (USD $)

3 Months Ended

1 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

12 Months Ended

3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Mar. 25, 2011

Aug. 03, 2010

Jan. 27, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Aug. 03, 2010

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Aug. 03, 2010

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Jan. 24, 2014

Jul. 31, 2012

Mar. 25, 2011

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Convertible Notes Payable [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Warrant [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Convertible Preferred Stock [Member]

Series A Convertible Preferred Stock [Member]

Series A Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series C Preferred Stock 2011 [Member]

Series C Preferred Stock 2011 [Member]

Series C Preferred Stock 2011 [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series E Preferred Stock [Member]

Series E Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Convertible Notes Payable [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

100,000

0

177,906

951,250

976,250

2,076,250

'

'

'

'

'

'

'

'

146,667

14,797

'

'

'

146,667

103,232

'

Preferred Stock, Par or Stated Value Per Share

'

'

$0.00

'

'

'

'

'

'

'

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

'

'

'

'

$1

'

'

'

'

'

'

$0.00

$0.00

$0.00

$0.00

'

Preferred Stock, Liquidation Preference Per Share

'

'

'

'

'

'

'

'

'

'

'

'

$3

'

'

'

'

'

$1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

591,666

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Preferred Stock and Preference Stock

'

'

'

'

'

'

'

'

'

$300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number Of Shares In Each Share On Conversion

'

'

0.12702

0.0635

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.0635

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion Of Series B Preferred Stock To Common Stock Share

'

'

'

'

'

'

69,864

34,931

'

'

0

0

'

'

'

'

'

'

'

25,000

1,100,000

550,000

'

1,587

69,864

34,931

'

'

'

0

0

'

'

'

Preferred Stock, Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

325,000

325,000

10,000,000

4,000,000

4,000,000

4,000,000

'

'

'

'

4,000,000

'

'

'

'

'

1,000,000

'

'

146,667

103,232

'

Stock Issued During Period, Value, Conversion of Convertible Securities

'

'

'

'

'

'

'

'

216,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

1,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

103,232

Debt Conversion, Converted Instrument, Amount

15

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

300,000

Interest Payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$9,698

Common_Stock_Details_Textual

Common Stock (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Common Stock Disclosure [Line Items]	'	'
Payments of Stock Issuance Costs	$90,766	$0
Common Stock [Member]	'	'
Common Stock Disclosure [Line Items]	'	'
Common Stock Issue Price Per Share	$0.00	'
Stock Issued During Period, Shares, New Issues	591,666	'
Proceeds from Issuance of Private Placement	1,774,999	'
Palladium Capital Advisors, LLC [Member]	'	'
Common Stock Disclosure [Line Items]	'	'
Warrants Issued During Period Number Of Warrants	22,083	'
Warrants Issued During Period Exercise Price Of Warrants	$3	'
Warrants Issued During Period Fair Value Of Warrants	62,241	'
Legal And Other Expense	90,766	'
Payments of Stock Issuance Costs	75,000	'
Fair Value Assumptions, Expected Volatility Rate	58.90%	'
Risk-Free Interest Rate	1.53%	'
Proceeds from Issuance of Warrants	1,684,233	'
Warrants Exercisable Term	'5 years	'
Expected Term	'5 years	'
Consultant [Member]	'	'
Common Stock Disclosure [Line Items]	'	'
Stock Issued During Period, Value, Issued for Services	123,744	'
Allocated Share-based Compensation Expense, Total	123,744	'
Stock Issued During Period, Shares, Issued for Services	30,000	'
Consultant Advisor [Member]	'	'
Common Stock Disclosure [Line Items]	'	'
Stock Issued During Period, Value, Issued for Services	6,056	'
Stock Issued During Period, Shares, Issued for Services	2,000	'
Professional Fees	6,056	'
First Month of Service [Member]	'	'
Common Stock Disclosure [Line Items]	'	'
Consultants Fees Under Joint Marketing Agreement	40,000	'
Second Month of Service [Member]	'	'
Common Stock Disclosure [Line Items]	'	'
Consultants Fees Under Joint Marketing Agreement	30,000	'
Third Month of Service [Member]	'	'
Common Stock Disclosure [Line Items]	'	'
Consultants Fees Under Joint Marketing Agreement	30,000	'
Four and Thereafter Months of Service [Member]	'	'
Common Stock Disclosure [Line Items]	'	'
Consultants Fees Under Joint Marketing Agreement	$10,000	'

StockBased_Compensation_Detail

Stock-Based Compensation (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Vendors [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected dividend yield	'	0.00%
Employees [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected dividend yield	0.00%	0.00%
Expected term	'3 years 9 months	'
Chief Operating Officer [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	'	1.90%
Expected dividend yield	'	0.00%
Expected volatility	'	189.81%
Expected term	'	'10 years
Executive Officer [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected dividend yield	'	0.00%
Expected term	'	'5 years
Employees One [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected dividend yield	'	0.00%
Expected term	'	'5 years
Maximum [Member] | Vendors [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	'	1.67%
Expected volatility	'	207.45%
Expected term	'	'10 years
Maximum [Member] | Employees [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	1.35%	1.91%
Expected volatility	56.95%	204.98%
Expected term	'	'10 years
Maximum [Member] | Executive Officer [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	'	0.69%
Expected volatility	'	205.26%
Maximum [Member] | Employees One [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	'	1.37%
Expected volatility	'	219.25%
Minimum [Member] | Vendors [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	'	0.67%
Expected volatility	'	194.68%
Expected term	'	'5 years
Minimum [Member] | Employees [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	1.19%	0.83%
Expected volatility	57.22%	196.04%
Expected term	'	'5 years
Minimum [Member] | Executive Officer [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	'	0.60%
Expected volatility	'	204.30%
Minimum [Member] | Employees One [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	'	0.54%
Expected volatility	'	204.36%

StockBased_Compensation_Detail1

Stock-Based Compensation (Details 1) (Employee Stock Option [Member], USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Stock Option [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of Options, Outstanding	557,413	439,611	'
Number of Options, Granted	59,332	144,333	'
Number of options, Exercised	0	0	'
Number of Options, Forfeited or Cancelled	-73,750	-26,531	'
Number of Options, Outstanding	542,995	557,413	439,611
Number of Options, Exercisable	275,296	320,373	'
Weighted Average Exercise Price, Outstanding	$4.98	$6.15	'
Weighted Average Exercise Price, Granted	$3.92	$3.04	'
Weighted Average Exercise Price, Exercised	$0	$0	'
Weighted Average Exercise Price, Forfeited or Canceled	$3.01	$13.16	'
Weighted Average Exercise Price, Outstanding	$5.14	$4.98	$6.15
Weighted Average Exercise Price, Exercisable	$6.81	$6.18	'
Weighted Average Remaining Contractual Life (In Years), Outstanding	'3 years 10 months 24 days	'4 years	'4 years 9 months 18 days
Weighted Average Remaining Contractual Life, Exercisable (in years)	'3 years 10 months 24 days	'4 years	'
Aggregate Intrinsic Value, Options Outstanding at Beginning Period	$5,250	$0	'
Aggregate Intrinsic Value, Options Outstanding at Ending Period	869,661	5,250	0
Aggregate Intrinsic Value, Options Exercisable at the end of the period	$404,577	$0	'

StockBased_Compensation_Detail2

Stock-Based Compensation (Details 2) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Options, Balance	237,040	263,765
Number of Options, Granted	59,332	144,333
Number of Options, Vested	-21,590	-146,243
Number of Option, Forfeited or Canceled	-7,083	-24,815
Number of Options, Balance	267,699	237,040
Weighted Average Grant Date Fair Value, Balance (in dollars per share)	$4.45	$8.40
Weighted Average Grant Date Fair Value, Granted	$1.52	$2.66
Weighted Average Grant Date Fair Value, Vested	($6.91)	($10.25)
Weighted Average Grant Date Fair Value, Forfeited or Canceled	($3.01)	($13.16)
Weighted Average Grant Date Fair Value, Balance (in dollars per share)	$3.66	$4.45

StockBased_Compensation_Detail3

Stock-Based Compensation (Details 3) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Series A Preferred Stock [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Warrants, Outstanding at start of the period	'	0	0	'
Number of Warrants, Granted	'	0	25,000	'
Number of Warrants, Exercised	'	0	0	'
Number of Warrants, Cancelled / Forfeited	'	0	-25,000	'
Number of Warrants, Outstanding at end of the period	'	0	0	0
Exercisable at the end of the period	'	0	'	'
Weighted Average Exercise Price, Outstanding at start of the period	'	$0	$0	'
Weighted Average Exercise Price, Granted	'	$0	$0.20	'
Weighted Average Exercise Price, Exercised	'	$0	$0	'
Weighted Average Exercise Price, Cancelled / Forfeited	'	$0	$0.20	'
Weighted Average Exercise Price, Outstanding at end of the period	'	$0	$0	$0
Weighted Average Exercise Price, Exercisable at end of the period	'	$0	'	'
Weighted Average Remaining Contractual Life, Outstanding (in years)	'	'0 years	'0 years	'0 years
Weighted Average Remaining Contractual Life, Exercisable (in years)	'	'0 years	'	'
Common Stock [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Warrants, Outstanding at start of the period	476,270	547,922	18,799	'
Number of Warrants, Granted	22,083	0	541,667	'
Number of Warrants, Exercised	0	-66,667	0	'
Number of Warrants, Cancelled / Forfeited	-216,667	-4,986	-12,543	'
Number of Warrants, Outstanding at end of the period	281,686	476,270	547,922	18,799
Exercisable at the end of the period	281,686	476,270	'	'
Weighted Average Exercise Price, Outstanding at start of the period	$3.02	$4.05	$194.40	'
Weighted Average Exercise Price, Granted	$3	$0	$3	'
Weighted Average Exercise Price, Exercised	$0	$3	$0	'
Weighted Average Exercise Price, Cancelled / Forfeited	$3	$117.84	$243.65	'
Weighted Average Exercise Price, Outstanding at end of the period	$3.04	$3.02	$4.05	$194.40
Weighted Average Exercise Price, Exercisable at end of the period	$3.04	$3.02	'	'
Weighted Average Remaining Contractual Life, Outstanding (in years)	'3 years	'3 years 1 month 6 days	'4 years	'1 year 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable (in years)	'3 years	'3 years 1 month 6 days	'	'
Aggregate Intrinsic Value, Options Outstanding at Beginning Period	$0	'	'	'
Aggregate Intrinsic Value, Options Outstanding at Ending Period	555,224	0	'	'
Aggregate Intrinsic Value, Options Exercisable at the end of the period	$555,224	'	'	'

StockBased_Compensation_Detail4

Stock-Based Compensation (Details 4) (Restricted Stock [Member])	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Restricted Stock [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Unvested, Number of shares, Outstanding at December 31, 2013	248,941	366,667
Granted, Number of shares	32,000	502,663	[1]
Cancelled, Number of shares	'	-216,667
Vested, Number of shares	-42,056	-403,722
Unvested, Number of shares, Outstanding at March 31, 2014	238,885	248,941
[1]	Includes 183,331 RSUS granted, but not considered issued or outstanding until vested.

StockBased_Compensation_Detail5

Stock-Based Compensation (Details 5) (Convertible Series A Preferred Stock [Member])	12 Months Ended
	Dec. 31, 2013
January 2012 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected dividends	0.00%
Expected term	'5 years
December 2012 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected dividends	0.00%
Expected volatility	209.62%
Expected term	'4 years
Risk-free interest rate	0.72%
March 2013 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected dividends	0.00%
Expected volatility	214.26%
Expected term	'4 years
Risk-free interest rate	0.81%
Maximum [Member] | January 2012 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected volatility	191.75%
Risk-free interest rate	0.88%
Minimum [Member] | January 2012 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected volatility	190.40%
Risk-free interest rate	0.71%

StockBased_Compensation_Detail6

Stock-Based Compensation (Details 6)	12 Months Ended
	Dec. 31, 2013
Warrants Without Reverse Split [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected dividends	0.00%
Expected volatility	189.81%
Expected term	'5 years
Risk free interest rate	0.75%
Warrants With Reverse Split [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected dividends	0.00%
Expected volatility	195.66%
Expected term	'5 years
Risk free interest rate	1.06%

StockBased_Compensation_Detail7

Stock-Based Compensation (Details Textual) (USD $)

3 Months Ended

12 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 25, 2011

Aug. 16, 2010

Aug. 03, 2010

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Jan. 31, 2012

Dec. 31, 2012

Jan. 27, 2014

Feb. 28, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Oct. 30, 2013

Jun. 08, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Nov. 18, 2011

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Aug. 03, 2010

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Jul. 31, 2012

Jan. 24, 2014

Mar. 25, 2011

Sep. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Apr. 24, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Aug. 03, 2010

Feb. 28, 2014

Mar. 31, 2014

Dec. 31, 2013

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Warrant [Member]

Warrant [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Stock Options Granted To Board Of Directors and Executive Officers For Future Services [Member]

Stock Options Granted To Board Of Directors and Executive Officers For Future Services [Member]

Stock Options Granted To Board Of Directors and Executive Officers For Future Services [Member]

Chief Executive Officer [Member]

Chairman [Member]

Third Party Consultant One [Member]

Third Party Consultant One [Member]

Third Party Consultant One [Member]

Third Party Consultant Two [Member]

Directors, Consultants And Employees [Member]

Directors, Consultants And Employees [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Restricted Stock Units (RSUs) [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

Series A Preferred Stock 2011 [Member]

Series A Preferred Stock 2011 [Member]

Series A Preferred Stock 2011 [Member]

Series A Preferred Stock 2011 [Member]

Series A Preferred Stock 2011 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series C Preferred Stock 2011 [Member]

Series C Preferred Stock 2011 [Member]

Series C Preferred Stock 2011 [Member]

Series D Preferred Stock 2012 [Member]

Series D Preferred Stock 2012 [Member]

Series D Preferred Stock 2012 [Member]

Series D Preferred Stock 2012 [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Common Stock [Member]

One Year Period [Member]

Four Year Period [Member]

Stock Option Grants To Two Advisors For Future Services [Member]

Stock Option Grants To Two Advisors For Future Services [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Operating Officer [Member]

Vendor [Member]

Vendor [Member]

Employees [Member]

Employees [Member]

Employees One [Member]

Employees One [Member]

Employees One [Member]

Board Of Directors [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Subsequent Event [Member]

Maximum [Member]

Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

'

'

'

4,000,000

'

'

'

'

'

1,000,000

'

'

'

350,000

'

'

'

'

'

'

'

4,000,000

4,000,000

4,000,000

'

'

146,667

146,667

Preferred stock, par value (in dollars per share)

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

$1

'

'

'

'

'

'

'

'

'

$0.00

'

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

'

'

$0.00

$0.00

Preferred Stock, Liquidation Preference Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

'

'

'

'

'

'

'

'

'

$10

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

Reverse Stock Split Ratio

'

'

'

'1-for-52.4846

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Converted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,356,000

'

'

'

'

'

'

'

'

'

'

'

'

'

350,000

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

Conversion Blocker Percentage

'

'

'

'

'

'

'

'

'

'

'

'

9.90%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9.99%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares issued in connection with convertible Series B preferred stock

'

'

'

'

'

'

'

'

'

'

'

'

'

1,587

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,785,333

'

'

'

'

'

'

'

'

'

1,879

'

'

'

1,166,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Liability, Fair Value, Gross Liability

'

'

$1,244,351

$153,776

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$105,900

'

$191,630

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

177,906

7,006,000

'

'

'

'

'

'

'

'

'

14,797

146,667

'

'

'

'

'

'

'

'

'

'

'

'

951,250

976,250

2,076,250

'

'

146,667

0

Number Of Shares In Each Unit

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number Of Warrants In Each Unit

'

'

'

'

'

'

3,176

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number Of Shares In Each Share On Conversion

'

'

'

'

0.12702

'

0.0635

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.0635

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fully Vested Common Stock Shares Granted During Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

233,333

300,000

'

'

110,667

1,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Granted Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

437,500

1,487,500

'

'

610,400

4,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation

316,947

938,751

2,147,763

3,586,431

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

805,238

2,140,947

'

'

'

'

'

'

'

114,759

380,801

1,342,525

1,445,484

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Options, Granted

'

'

'

'

'

'

'

'

'

'

'

533,333

'

'

'

'

'

'

'

'

'

'

'

'

'

32,000

502,663

[1]

'

'

'

'

400,000

59,332

'

'

'

'

275,667

33,333

'

31,667

'

22,035

144,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'During the third quarter of 2012, our Board amended the conversion rights on the 2012 Series D PS such that it became convertible immediately prior to the closing of a Combined Transaction or the occurrence of the Liquidation Event, both as defined in the Certificate of Designation, as amended.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

'

'

'

'

'

'

'

'

'

'

'

'

'

'

69,000

66,666

140,000

'

'

'

'

'

'

'

'

'

'

16,666

'

66,666

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Liability, Fair Value, Net

0

'

1,001,385

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

134,664

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,472,094

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Conversion Basis

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'shares at a rate of 3.33 shares of common for each share of 2012 Series D PS

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Change in fair value of derivative liability - convertible notes payable

-681,122

0

149,398

28,244

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

47,876

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'22 months

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

720,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allocated Share-based Compensation Expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

437,500

1,487,500

'

30,450

579,950

'

'

'

'

270,000

60,000

'

'

'

'

15,695

'

'

'

291,525

543,948

3,100

19,563

13,070

9,158

11,904

35,490

'

'

21,083

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

'

'

$0.30

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Shares, Vested

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,500

'

'

'

'

'

'

'

5,556

5,556

150,000

33,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Exercise Price, Granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3

$3

'

$3

'

$3

'

$4.50

$3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

'

'

'

'

'

'

'

0

'

555,224

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,289,250

3,150

48,935

'

'

0

384,387

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Payments for Fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

'

'

'

25,000

'

'

'

'

'

'

43,042

'

'

'

'

'

'

'

'

21,195

35,100

'

'

'

'

'

'

'

27,668

16,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Professional Fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

13,095

25,538

'

4,000

'

'

'

'

'

'

16,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,500

13,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Preferred Stock and Preference Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,361,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,361,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

951,250

976,250

2,076,250

'

'

146,667

0

Convertible Notes Payable, Current

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Payments of Stock Issuance Costs

90,766

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

27,282

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Shares Issued To Be Converted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,335,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Shares Issued To Be Converted Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

86.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number Of Shares Under Price Protection Feature

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,006,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage Of Ownership Of Investors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9.99%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Conversion of Convertible Securities

'

'

'

'

'

'

'

'

490,698

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Liability Reclassified Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,992,934

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,089,744

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares Authorized

650,000,000

'

650,000,000

650,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share

$0.00

'

$0.00

$0.00

'

'

'

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued On Settlement Of Debt

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued On Reverse Split

'

'

'

8,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price

'

'

'

$3

'

'

'

'

'

'

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3.92

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement By Share Based Payment Award Vesting Over Six Month Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement By Share Based Payment Award Vesting Over Two Year Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

16,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,002,764

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'4 years 2 months 12 days

'4 years 3 months 18 days

'

'

'

'

'

'

'

'3 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.80

'

'

'

'

'

'

$2.66

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

597,454

620,979

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

183,331

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3.45

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Grant Date Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

632,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vesting Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'The restricted stock vests quarterly over a three year period with the first vesting date being December 31, 2013, subject to continued service on each applicable vesting date. Additionally, the restricted stock will automatically vest under certain circumstances including in the event of a change of control of the Company.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'The RSUs vest annually over a five year period with the first vesting date being October 31, 2014, subject to continued service on each applicable vesting date. Additionally, the RSUs will automatically vest under certain circumstances including in the event of a change of control of the Company.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion Of Series Preferred Stock To Common Stock Share

'

'

'

'

'

'

'

59,302

2,276,031

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

59,302

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-177,906

-6,828,094

0

0

0

0

'

'

'

'

'

'

'

Conversion of Stock, Conversion Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.33

'

'

'

'

$0.06

$0.06

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.06

'

'

Conversion Of Series B Preferred Stock To Common Stock Share

'

'

'

'

'

'

'

69,864

34,931

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

1,100,000

550,000

'

1,587

69,864

34,931

'

'

'

'

'

'

'

'

0

0

-1,100,000

-550,000

0

0

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

284,296

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividend Arising From Beneficial Conversion Feature

'

'

'

191,630

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

0

'

0

'

'

'

'

'

'

'

Share based Compensation Arrangement By Share based Payment Award Options Grants In Period Grant Date Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

90,431

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,500

'

'

'

'

'

'

'

5,556

5,556

150,000

33,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted Stock or Unit Expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$27,668

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

Includes 183,331 RSUS granted, but not considered issued or outstanding until vested.

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2013
Commitments and Contingencies [Line Items]	'
2014	$77,625
2015	51,750
Total	$129,375

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies [Line Items]	'	'
Lease Expiration Date	31-Aug-15	'
Operating Leases, Rent Expense	$95,000	$51,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	216,667	'
Sergio Zyman [Member] | Restricted Stock [Member]	'	'
Commitments and Contingencies [Line Items]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period	66,666	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Line Items]	'	'
Domestic loss	($4,442,000)	($8,849,000)
Foreign income (loss)	179,000	0
Consolidated net loss before income tax expense	($4,263,000)	($8,849,000)

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current deferred tax assets:	'	'
Accrued Expenses	$30,000	$119,000
Allowance for Doubtful Accounts	1,000	38,000
Subtotal current deferred tax asset	31,000	157,000
Non-current deferred tax assets and liabilities:	'	'
Intangible Assets	27,000	29,000
Fixed Assets	-123,000	-112,000
Discount on Convertible Notes	-329,000	0
Derivative Liability	377,000	0
Stock Options	2,477,000	1,972,000
Net operating loss carryover	8,652,000	7,322,000
Subtotal non-current deferred tax asset	11,081,000	9,211,000
Total deferred tax asset	11,112,000	9,368,000
Less: valuation allowance	-11,112,000	-9,368,000
Net deferred tax assets	$0	$0

Income_Taxes_Details_2

Income Taxes (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Line Items]	'	'
Expected tax expense (benefit) - federal	($1,449,000)	($3,009,000)
Expected tax expense (benefit) - state	-159,000	-321,000
Foreign rate differential	-23,000	0
Change in fair value of derivative liability - embedded conversion feature	0	776,000
Permanent items	22,000	1,000
True-up	-135,000	0
Change in valuation allowance	1,744,000	2,553,000
Actual tax expense	$0	$0

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Line Items]	'	'
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	34.00%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent	5.50%	5.50%
Effective Income Tax Rate Reconciliation Blended Tax Rate	37.63%	37.63%
Deferred Tax Assets, Valuation Allowance	$11,112,000	$9,368,000
Valuation Allowance, Deferred Tax Asset, Change in Amount	1,744,000	'
Operating Loss Carryforwards	$23,320,000	'
Operating Loss Carryforwards Expiration Period	'	'expiring through 2033

Related_Party_Transactions_Det

Related Party Transactions (Details Textual) (Digital Connect Solutions, Inc [Member], USD $)	12 Months Ended	1 Months Ended
	Dec. 31, 2013	Jan. 31, 2014
		Subsequent Event [Member]
Related Party Transaction [Line Items]	'	'
Payments for Commissions	$29,691	$3,622
Percentage of Commission under Commissions Agreement	25.00%	'

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

2 Months Ended

1 Months Ended

1 Months Ended

0 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Jan. 27, 2012

Dec. 31, 2013

Apr. 15, 2014

Jan. 27, 2014

Feb. 28, 2014

Mar. 31, 2014

Feb. 28, 2014

Feb. 28, 2014

Feb. 28, 2014

Jan. 27, 2014

Feb. 28, 2014

Jan. 27, 2014

Jan. 30, 2014

Apr. 10, 2014

Apr. 10, 2014

Apr. 10, 2014

Apr. 10, 2014

Jan. 27, 2014

Jan. 27, 2014

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Investor [Member]

Investor [Member]

Private Placement [Member]

Private Placement [Member]

Convertible Notes Payable One [Member]

Convertible Notes Payable Two [Member]

Series B Convertible Preferred Stock [Member]

Joint Marketing Agreement [Member]

Common Stock [Member]

Common Stock [Member]

Advisor [Member]

Doug Feirstein [Member]

Michael Brauser [Member]

Chief Executive Officer [Member]

Chief Operating Officer [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Joint Marketing Agreement [Member]

Common Stock [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Series A Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Subsequent Event [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30,000

2,000

'

'

'

'

'

'

Professional Fees, Due In First Month Of Service

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$40,000

'

'

'

'

'

'

'

'

'

Professional Fees, Due In Second Month Of Service

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30,000

'

'

'

'

'

'

'

'

'

Professional Fees, Due In Third Month Of Service

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30,000

'

'

'

'

'

'

'

'

'

Professional Fees Due, Per Month, After Third Month Of Service

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

591,666

'

'

'

'

'

'

'

'

591,667

'

'

'

'

'

'

'

'

'

'

'

100,000

'

Proceeds From Issuance Of Convertible Preferred Stock

300,000

0

0

3,361,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

300,000

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

146,667

Stock Issued During Period, Shares, For warrant Exercises

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

146,667

Number Of Warrants Exercised

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

216,667

Conversion Blocker Percentage

'

'

'

'

'

'

'

'

'

'

'

9.90%

'

'

'

9.90%

'

'

'

'

'

'

'

'

'

'

'

Conversion Of Stock, Shares Converted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

Conversion Of Stock, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,587

'

'

'

'

'

'

'

'

Conversion of Stock, Conversion Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.06

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, New Issues

'

'

'

'

'

'

'

'

'

'

'

'

'

1,775,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Original Debt, Amount

'

'

0

800,000

'

'

'

'

'

100,000

'

'

'

'

820,000

300,000

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

'

'

1,600,000

'

'

'

'

'

383,659

103,232

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued, Number of Warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

22,083

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued, Expiration Period

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued, Exercise Price

'

'

'

'

'

'

'

'

'

'

'

'

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Common Stock

1,774,999

0

'

'

'

'

'

'

'

'

'

'

'

1,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150,000

150,000

'

'

Class of Warrant or Right, Outstanding

'

'

'

'

281,686

476,270

547,922

18,799

'

'

'

'

'

'

'

'

'

'

'

'

'

33,333

216,666

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

3

'

'

'

'

Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'5 years

'

'

Stock Registered for Future Issuance Percentage of Overallotment Option

'

'

'

'

'

'

'

'

'

'

15.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right Expiration Period of Warrants or Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'5 years

'

'

'

'

Stock Registered For Future Issuance Value

'

'

'

'

'

'

'

'

'

'

$10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'